These Top 4 Women-Run Company Stocks Are Quietly Beating the Market
- These women-run company stocks offer high growth and stability.
- 07/02/2025
|
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"
- McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market.
- 07/01/2025
|
5 Top-Ranked Dividend Growth Stock Picks for the Second Half of 2025
- AEM, NTES, QFIN, UGI and MCK stand out as strong dividend growth picks for steady income and upside in 2H25.
- 06/30/2025
|
McKesson Corporation Announces First Quarter Fiscal 2026 Earnings Release Date
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson's Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services lea.
- 06/26/2025
|
Calls of the Day: ServiceNow, S&P Global, McKesson Corp., Ross Stores, TJX and Burlington
- The Investment Committee debate the latest Calls of the Day.
- 06/25/2025
|
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
- McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
- 06/25/2025
|
Bargain Alert: I'm Buying Monthly Dividends Up To 7% Yield
- Timing of income is an important consideration. Monthly dividend stocks provide recurring income and faster compounding of wealth. I highlight two monthly dividend payers that are undervalued while supporting well-covered yields. Both carry strong balance sheets with A- and BBB+ credit ratings and durable business models that support growth for years to come.
- 06/24/2025
|
4 Stocks With Solid Shareholder Yield to Safeguard Your Portfolio
- MCK, LRCX, CTSH, and RITM stand out with strong shareholder yield, blending income, buybacks and debt reduction for portfolio defense.
- 06/23/2025
|
Our Top 10 High Growth Dividend Stocks - June 2025
- The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth quality scores, and positive momentum, suitable for investors in the accumulation phase.
- 06/21/2025
|
Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?
- Here is how McKesson (MCK) and Benitec Biopharma Limited (BNTC) have performed compared to their sector so far this year.
- 06/20/2025
|
Here's Why McKesson (MCK) is a Strong Value Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 06/18/2025
|
Why McKesson (MCK) is a Top Growth Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 06/17/2025
|
McKesson (MCK) Rises Higher Than Market: Key Facts
- McKesson (MCK) concluded the recent trading session at $730.80, signifying a +1.82% move from its prior day's close.
- 06/12/2025
|
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
- Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- 06/11/2025
|
McKesson to Host Investor Day on September 23, 2025
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced it will host an Investor Day on Tuesday, September 23, 2025, in New York City. The event will feature presentations by McKesson's leadership team followed by a Q&A session with chief executive officer Brian Tyler and chief financial officer Britt Vitalone. Management will provide an update on the company's strategic priorities, growth strategies, and business outlook. A live webcast of the event and replay, along wit.
- 06/11/2025
|
McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why
- McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 06/03/2025
|
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
- Here is how McKesson (MCK) and Adagene Inc. Sponsored ADR (ADAG) have performed compared to their sector so far this year.
- 06/03/2025
|
Why McKesson (MCK) is a Top Value Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 05/29/2025
|
Here's Why McKesson (MCK) is a Strong Momentum Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 05/28/2025
|
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
- McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
- 05/28/2025
|
MCK vs. CAH: Which Drug Distribution Giant Has the Healthier Outlook?
- Both McKesson and Cardinal Health dominate drug distribution, but which stock offers better growth and stability in 2025? Here we discuss which company has better long-term potential.
- 05/27/2025
|
Is McKesson (MCK) a Buy as Wall Street Analysts Look Optimistic?
- Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
- 05/22/2025
|
MCK Stock Gains More Than 4% Following Strong Q4: Should You Buy Now?
- McKesson's MCK shares have gained 4.4% following its fourth-quarter fiscal 2025 earnings release on May 9. The post-earnings upside reflects growing investor confidence in McKesson's strategic execution and long-term positioning, underpinned by record full-year revenues of $359 billion and a 20% year-over-year increase in adjusted earnings per share (to $33.05).
- 05/19/2025
|
McKesson: Sustained Rally Backed By Strong Financials
- The stock price of McKesson has maintained a strong upward trend throughout multiple years because of its solid financial performance and dedicated investor support which creates a defensive investment opportunity. The company achieves strong revenue and EPS growth through its expanding oncology, biopharmaceutical and GLP-1 therapy sales, which counterbalance the typical thin margins of the sector. The company's strategic focus on high-growth segments together with its divestment of slow-growth units makes McKesson an attractive long-term investment despite its high valuation and low yield.
- 05/18/2025
|
Our Top 10 High-Growth Dividend Stocks -- May 2025
- The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rate quantitatively and qualitatively, and select the top ten names from an initial list of nearly 400 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth quality scores, and positive momentum, suitable for investors in the accumulation phase.
- 05/17/2025
|
McKesson To Spin-Off Its Medical-Surgical Solutions Business
- Deal OverviewOn May 8, 2025, McKesson Corporation (NYSE: MCK, $682.28, Market Capitalization: $85.4 billion), a diversified healthcare services company, announced its intention to separate its Medical-Surgical Solutions segment into an independent company (NewCo) (for more information, visit spinoffresearch.com). McKesson is committed to exploring all opportunities to execute a separation in a manner that maximizes shareholder value and anticipates providing more information as appropriate on the form and timing as the process progresses.
- 05/15/2025
|
3 Reasons Growth Investors Will Love McKesson (MCK)
- McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market.
- 05/14/2025
|
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
- Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- 05/14/2025
|
McKesson Corporation (MCK) CFO Britt Vitalone Hosts BofA Securities 2025 Healthcare Conference (Transcript)
- McKesson Corporation (NYSE:MCK ) BofA Securities 2025 Healthcare Conference May 13, 2025 11:00 AM ET Company Participants Britt Vitalone - Chief Financial Officer Conference Call Participants Allen Lutz - Bank of America Allen Lutz Welcome to day one of the BofA Healthcare Conference here in Las Vegas. We are very excited to welcome McKesson here.
- 05/13/2025
|
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 05/12/2025
|
Why McKesson Stock Bumped Modestly Higher Today
- Storied healthcare supplies company McKesson (MCK 0.34%) was a slight outperformer on the stock exchange Friday, as investors considered its results for its fourth quarter of fiscal 2025. They liked, if not loved, what they saw, sending the shares to a 0.5% gain on that day.
- 05/09/2025
|
McKesson: Spinoff Of Medical-Surgical Solutions Is A Positive, Strong Buy
- I reiterate a Strong Buy rating on McKesson Corporation with a fair value of $828 per share, driven by robust growth in the oncology and biopharma sectors. McKesson posted 19% revenue growth and 63.8% adj. EPS growth, largely driven by strong demand for GLP-1 products, which now represent 12% of total revenue. The company's global supply chain flexibility and non-discretionary drug pricing render it largely immune to tariff uncertainties, ensuring stable future growth.
- 05/09/2025
|
MCK Stock Up on Q4 Earnings Beat & Potential Surgical Biz Spin-Off
- McKesson's fourth-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.
- 05/09/2025
|
McKesson Corporation (MCK) Q4 2025 Earnings Call Transcript
- McKesson Corporation (NYSE:MCK ) Q4 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Brian Tyler - Chief Executive Officer Britt Vitalone - Chief Financial Officer Jeni Dominguez - VP of Investor Relations Conference Call Participants Kevin Caliendo - UBS Lisa Gill - JP Morgan Allen Lutz - Bank of America Eric Percher - Nephron Research Stephen Baxter - Wells Fargo Daniel Grosslight - Citi Eric Coldwell - Baird Elizabeth Anderson - Evercore ISI Charles Rhyee - TD Cowen Operator Presentation Operator Welcome to McKesson's Fourth Quarter Fiscal 2025 Earnings Conference Call. Please be advised that today's conference is being recorded.
- 05/08/2025
|
Here's What Key Metrics Tell Us About McKesson (MCK) Q4 Earnings
- While the top- and bottom-line numbers for McKesson (MCK) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 05/08/2025
|
McKesson (MCK) Tops Q4 Earnings Estimates
- McKesson (MCK) came out with quarterly earnings of $10.12 per share, beating the Zacks Consensus Estimate of $9.81 per share. This compares to earnings of $6.18 per share a year ago.
- 05/08/2025
|
McKesson to spin off surgical supplies unit, forecasts strong annual profit
- McKesson forecast fiscal 2026 profit largely above estimates on Thursday and said it is planning to spin off its medical-surgical solutions unit into an independent company to focus on its core drug distribution business.
- 05/08/2025
|
McKesson to Spin Off Medical-Surgical Company
- The pharmaceutical distributor said the new company would be a differentiated medical surgical supply and solutions business.
- 05/08/2025
|
McKesson Reports Fiscal 2025 Fourth Quarter and Full Year Results and Provides Fiscal 2026 Guidance; Announces Intent to Separate Medical-Surgical Solutions
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2025 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Thursday, May 8th at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and arc.
- 05/08/2025
|
How To Earn $500 A Month From McKesson Stock Ahead Of Q4 Earnings
- McKesson Corporation MCK will release its fourth-quarter financial results after the closing bell on Thursday.
- 05/08/2025
|
Brokers Suggest Investing in McKesson (MCK): Read This Before Placing a Bet
- Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
- 05/06/2025
|
MCK Stock Up 24% YTD: Should You Buy, Hold or Sell Before Q4 Earnings?
- McKesson's fourth-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.
- 05/06/2025
|
McKesson (MCK) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
- Besides Wall Street's top -and-bottom-line estimates for McKesson (MCK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
- 05/05/2025
|
McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 05/01/2025
|
McKesson (MCK) Laps the Stock Market: Here's Why
- McKesson (MCK) closed at $712.79 in the latest trading session, marking a +0.78% move from the prior day.
- 04/30/2025
|
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
- Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopharmaceutical quality control, new regulations, and product replacement cycles, targeting high single to low double-digit revenue growth. Penumbra's mechanical thrombectomy devices target underpenetrated markets with potential FDA approval for Thunderbolt device as a growth catalyst.
- 04/29/2025
|
McKesson (MCK) Rises Higher Than Market: Key Facts
- McKesson (MCK) reachead $699.73 at the closing of the latest trading day, reflecting a +0.68% change compared to its last close.
- 04/28/2025
|
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
- McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 04/24/2025
|
McKesson Shares Rise Nearly 1% After Key Signal
- MCK moves higher through the session after Alert
- 04/24/2025
|
McKesson (MCK) Increases Yet Falls Behind Market: What Investors Need to Know
- In the latest trading session, McKesson (MCK) closed at $695.17, marking a +1.86% move from the previous day.
- 04/22/2025
|
McKesson (MCK) Ascends While Market Falls: Some Facts to Note
- In the most recent trading session, McKesson (MCK) closed at $694.70, indicating a +0.27% shift from the previous trading day.
- 04/16/2025
|
McKesson Unveils Precision Care Companion, Revolutionizing Precision Medicine in Community Oncology
- IRVING, Texas--(BUSINESS WIRE)--McKesson launched an initiative addressing the clinical challenges and administrative burden practices face in the era of biomarker-directed care.
- 04/16/2025
|
3 Safe Dividend Stocks as Investors Seek to Reset Diversification
- Over the last three years, diversification has fallen out of fashion. When investors can make 20% or higher returns in technology stocks and even more from the Magnificent 7, the idea of investing in low-growth dividend stocks loses some appeal.
- 04/11/2025
|
Why the Market Dipped But McKesson (MCK) Gained Today
- McKesson (MCK) closed the most recent trading day at $679.33, moving +1.13% from the previous trading session.
- 04/10/2025
|
Registration Opens for Annual McKesson ideaShare Conference
- IRVING, Texas--(BUSINESS WIRE)--Register to attend McKesson ideaShare, a premier community pharmacy annual education and networking event, in Nashville from July 10-13, 2025.
- 04/08/2025
|
MCK Stock Gains as PRISM Acquisition Adds High-Growth Business
- McKesson acquires 80% ownership in PRISM Vision Holdings, diversifying its business into the high-growth area of ophthalmology. The deal is to be accretive this year.
- 04/03/2025
|
McKesson Shares Up Over 2% After Key Signal
- MCK IS UP OVER 14 POINTS AFTER THE TRADEPULSE ALERT
- 04/03/2025
|
McKesson Gets Drugs to Patients. Buy the Stock for Healthy Returns.
- An aging U.S. population is increasing the demand for medication, and this company delivers.
- 04/03/2025
|
McKesson Corporation Completes Acquisition of PRISM Vision Holdings, LLC
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) today announced the completion of its previously announced acquisition of a controlling interest in PRISM Vision Holdings, LLC, a leading provider of general ophthalmology and retina management services. McKesson acquired an approximate 80% controlling interest in PRISM Vision Holdings, an ophthalmology and retina management services provider, for about $850 million. PRISM physicians will retain an approximate 20% interest. The ac.
- 04/02/2025
|
McKesson (MCK) Laps the Stock Market: Here's Why
- In the most recent trading session, McKesson (MCK) closed at $672.99, indicating a +0.74% shift from the previous trading day.
- 03/31/2025
|
Wall Street Bulls Look Optimistic About McKesson (MCK): Should You Buy?
- Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
- 03/28/2025
|
McKesson: Immune To Weak Economy And Tariffs; Top Idea In 2025
- I maintain a 'Strong Buy' rating on McKesson with a fair value of $723 per share due to its robust oncology network and strong growth prospects. McKesson's minimal exposure to US-Mexico-Canada tariffs and geopolitical tensions ensures stability, making it a reliable investment amid economic uncertainties. The company's GLP-1 and oncology franchises are key growth drivers, with GLP-1 revenue growing 45% year-over-year and oncology patient visits increasing steadily.
- 03/25/2025
|
McKesson (MCK) Stock Drops Despite Market Gains: Important Facts to Note
- McKesson (MCK) closed at $660.86 in the latest trading session, marking a -0.05% move from the prior day.
- 03/24/2025
|
Trade Tracker: Joe Terranova buys Interactive Brokers and McKesson, sells CVS
- Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to detail his latest portfolio moves.
- 03/24/2025
|
McKesson (MCK) and Visa (V) Are 2 Dividend Growth Stocks to Buy For a Lifetime of Passive Income
- Investing in dividend growth stocks is a smart, reliable way to build passive income that lasts a lifetime, and it's worth considering if you're eyeing financial freedom.
- 03/22/2025
|
McKesson (MCK) Increases Yet Falls Behind Market: What Investors Need to Know
- In the latest trading session, McKesson (MCK) closed at $663.79, marking a +0.33% move from the previous day.
- 03/19/2025
|
McKesson (MCK) Advances While Market Declines: Some Information for Investors
- McKesson (MCK) closed at $643.69 in the latest trading session, marking a +0.47% move from the prior day.
- 03/13/2025
|
3 Stocks to Consider With a Possible Recession on the Table
- As of early March 2025, investors—and consumers—have once again begun to feel skittish about the possibility of an impending recession. At least two major factors have contributed most recently to this sentiment: first, a dreaded inverted yield curve in the final days of February, and second, the Atlanta Fed's model to predict GDP growth for the first quarter of the year was revised down to -2.8% on March 3, when it had been +4.0% about a month before.
- 03/10/2025
|
McKesson Keeps Growing, Eyeing Bigger Future
- Health care product distributor McKesson Corporation (MCK) reports big earnings gains, eye care acquisition.
- 03/05/2025
|
McKesson Corporation (MCK) TD Cowen 45th Annual Healthcare Conference Transcript
- McKesson Corporation (NYSE:MCK ) TD Cowen 45th Annual Healthcare Conference Call March 4, 2025 9:50 AM ET Company Participants Britt Vitalone – Executive Vice President and Chief Financial Officer Conference Call Participants Unidentified Analyst Good morning. Thanks for joining us for the next session here at the TD Cowen Healthcare Conference and very pleased to have with us McKesson.
- 03/04/2025
|
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
- Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- 02/26/2025
|
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
- Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- 02/11/2025
|
Should You Buy, Hold or Sell MCK Stock Following Robust Q3 Earnings?
- McKesson MCK delivered an 18% increase in revenues ($95.3 billion) and a 16% rise in adjusted operating profit during the third quarter of fiscal 2025 despite ongoing macroeconomic challenges. The company also raised its full-year guidance.
- 02/11/2025
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
- Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- 02/07/2025
|
MCK Stock Down on Q3 Earnings & Sales Miss, Gross Margin Contracts
- McKesson's third-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.
- 02/06/2025
|
McKesson Corporation (MCK) Q3 2025 Earnings Call Transcript
- McKesson Corporation. (NYSE:MCK ) Q3 2025 Earnings Conference Call February 5, 2025 4:30 PM ET Company Participants Rachel Rodriguez - VP of Investor Relations Brian Tyler - Chief Executive Officer Britt Vitalone - Executive Vice President and Chief Financial Officer Conference Call Participants Eric Percher - Nephron Research Kevin Caliendo - UBS Allen Lutz - Bank of America Brian Tanquilut - Jefferies Lisa Gill - JPMorgan Stephen Baxter - Wells Fargo Erin Wright - Morgan Stanley George Hill - Deutsche Bank Daniel Grosslight - Citi Operator Welcome to McKesson's Third Quarter Fiscal 2025 Earnings Conference Call.
- 02/05/2025
|
Here's What Key Metrics Tell Us About McKesson (MCK) Q3 Earnings
- While the top- and bottom-line numbers for McKesson (MCK) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 02/05/2025
|
McKesson (MCK) Q3 Earnings and Revenues Miss Estimates
- McKesson (MCK) came out with quarterly earnings of $8.03 per share, missing the Zacks Consensus Estimate of $8.04 per share. This compares to earnings of $7.74 per share a year ago.
- 02/05/2025
|
McKesson misses third-quarter revenue estimates
- Drug distributor McKesson missed estimates for third-quarter revenue on Wednesday, hurt by less-than-expected sales in its U.S. pharmaceutical segment, which includes branded and specialty drugs.
- 02/05/2025
|
McKesson Exceeds EPS, Q3 Profit Surges
- Healthcare distribution and services specialist McKesson (MCK 0.59%) reported mixed financial results for fiscal 2025's third quarter on Wednesday, Feb. 5. McKesson beat earnings expectations with an adjusted EPS of $8.03, coming in just ahead of the projected $8.01.
- 02/05/2025
|
McKesson Corporation Reports Fiscal 2025 Third Quarter Results and Raises Full Year Adjusted EPS Guidance
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2025 third quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, February 5th at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live an.
- 02/05/2025
|
McKesson Stock May Rise With PRISM Vision Holdings Acquisition
- MCK is set to acquire a controlling stake in PRISM Vision Holdings, aiming to expand its specialty care capabilities and strengthen its leadership in eye health solutions across the United States.
- 02/05/2025
|
MCK Stock Before Q3 Earnings: A Smart Buy or Risky Investment?
- McKesson's third-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.
- 02/04/2025
|
McKesson (MCK) Declines More Than Market: Some Information for Investors
- In the closing of the recent trading day, McKesson (MCK) stood at $594.75, denoting a -1.63% change from the preceding trading day.
- 01/31/2025
|
Gear Up for McKesson (MCK) Q3 Earnings: Wall Street Estimates for Key Metrics
- Evaluate the expected performance of McKesson (MCK) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- 01/31/2025
|
McKesson Corporation Declares Quarterly Dividend
- IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 71 cents per share of common stock. The dividend will be payable on April 1, 2025, to stockholders of record on March 3, 2025. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers.
- 01/30/2025
|
McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 01/29/2025
|
McKesson (MCK) Stock Drops Despite Market Gains: Important Facts to Note
- McKesson (MCK) closed at $602.95 in the latest trading session, marking a -0.24% move from the prior day.
- 01/28/2025
|
McKesson's Practice Insights Selected as a 2025 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services
- IRVING, Texas--(BUSINESS WIRE)--For the ninth year, CMS has named McKesson a Qualified Clinical Data Registry approved to participate in the Merit-based Incentive Payment System.
- 01/23/2025
|
McKesson (MCK) Stock Declines While Market Improves: Some Information for Investors
- McKesson (MCK) closed at $586.08 in the latest trading session, marking a -1.1% move from the prior day.
- 01/21/2025
|
Wall Street Analysts Think McKesson (MCK) Is a Good Investment: Is It?
- Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
- 01/21/2025
|
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
- McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
- 01/21/2025
|
MCK Stock Gains 4% in 3 Weeks: Should You Buy, Hold or Sell?
- McKesson MCK has started 2025 on a positive note, with the stock climbing 4% so far in January as investors remain optimistic about the company's performance in 2025. MCK's growth this year will be driven by its strategic focus on oncology and biopharma services, supported by the expansion of The US Oncology Network and the launch of InspiroGene for cell and gene therapies.
- 01/21/2025
|
Here's Why McKesson (MCK) is a Strong Value Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 01/15/2025
|
Should Value Investors Buy McKesson (MCK) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 01/14/2025
|
McKesson (MCK) Surpasses Market Returns: Some Facts Worth Knowing
- McKesson (MCK) concluded the recent trading session at $585.08, signifying a +0.57% move from its prior day's close.
- 01/13/2025
|
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
- McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 01/08/2025
|
McKesson Stock Declines Post Divestiture of Canada-Based Businesses
- MCK aims to focus on capital deployment and prioritize investments to strengthen its strategic oncology and biopharma growth platforms.
- 01/02/2025
|
McKesson Corporation Completes Divestiture of Canada-Based Rexall and Well.ca Businesses
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) reported today that on December 30, 2024 it has closed the transaction announced in September 2024 to sell its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, a Canadian private equity firm. This transaction enables the Company to focus capital deployment and prioritize investments expanding its strategic oncology and biopharma growth platforms. Additional details related to the divestiture can be found o.
- 12/31/2024
|
Why McKesson (MCK) is a Top Value Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 12/30/2024
|
5 Beaten-Down MedTech Stocks Set to Rebound in 2025
- Investors may want to take a closer look at discounted stocks, such as MCK, HAE, ARAY, LIVN and PBH, in the present market landscape.
- 12/30/2024
|
McKesson Corporation Announces Third Quarter Fiscal 2025 Earnings Release Date and Participation in January Conference
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2025 financial results after market close on Wednesday, February 5, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will be participating in the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025.
- 12/30/2024
|
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
- McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
- 12/25/2024
|
Are Investors Undervaluing McKesson (MCK) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 12/23/2024
|
4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025
- Investing in large-cap MedTech stocks like MCK, PEN, CAH and PEN can be profitable for investors in 2025.
- 12/20/2024
|
Best Growth Stocks to Buy for December 20th
- Here are three stocks with buy ranks and strong growth characteristics for investors to consider today December 20th:
- 12/20/2024
|
Buy 5 Value Stocks Amid Strong Upside Potential in the Short Term
- Five value stocks have strong revenues and earnings potential in 2025. These are: FAF, MCK, LDOS, SKYW, GAP.
- 12/20/2024
|
3 Top Ranked Stocks to Buy for 2025 (GPOR, MCK, MRVL)
- Following Wednesday's FOMC meeting and press conference from Jerome Powell, it seems 2025 may be shaping up to be a bit more uncertain than investors were expecting. Powell expressed his concern about rising inflation and signaled the central bank was going to be more hawkish moving forward.
- 12/19/2024
|
Best Growth Stocks to Buy for December 19th
- Here are three stocks with buy ranks and strong growth characteristics for investors to consider today December 19th:
- 12/19/2024
|
Best Growth Stocks to Buy for December 18th
- Here are three stocks with buy ranks and strong growth characteristics for investors to consider today December 18th:
- 12/18/2024
|
Best Value Stocks to Buy for December 18th
- LTM, BBAR and MCK made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 18, 2024.
- 12/18/2024
|
Reasons to Add McKesson Stock to Your Portfolio Right Now
- MCK's strategic collaborations and strength in Biologics raise optimism about the stock.
- 12/18/2024
|
Prescription for Profits: 3 Must-Buy Healthcare Stocks Before 2025
- The healthcare sector is undergoing significant changes, with technology, innovation and a patient-centric approach as the cornerstones of its growth.
- 12/16/2024
|
Best Growth Stocks to Buy for December 16th
- Here are three stocks with buy ranks and strong growth characteristics for investors to consider today December 16th:
- 12/16/2024
|
Best Value Stocks to Buy for December 16th
- ZIM, MCK and DFH made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 16, 2024.
- 12/16/2024
|
Zacks Industry Outlook Becton, Dickinson, BD, McKesson, Cardinal Health and Merit Medical Systems
- Becton, Dickinson, BD, McKesson, Cardinal Health and Merit Medical Systems have been highlighted in this Industry Outlook article.
- 12/13/2024
|
Here's Why McKesson (MCK) is a Strong Value Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 12/12/2024
|
4 Stocks to Watch Amid Dental Supplies Industry Challenges
- Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are BDX, MCK, CAH and MMSI.
- 12/12/2024
|
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
- Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- 12/11/2024
|
12 High-Yield Dividend Aristocrats To Weather The Coming 2025 Storm In Style
- The S&P is up almost 28% in 2024, and many investors worry about a melt-up followed by a sharp correction like in 2022 or 2018. A 2025 market correction is likely, but low-volatility, high-yield Dividend Aristocrats offer a better alternative to the traditional 60-40 portfolio and S&P. These 12 Aristocrats provide a 3.2% yield, 14% discount, 22% upside potential next year, and 10% long-term income growth consensus, while being 54% lower volatility than the S&P.
- 12/07/2024
|
Jim Cramer Says 4 Large Cap Dividend Stocks Are Sizzling December Buys
- Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%.
- 12/06/2024
|
McKesson Corporation (MCK) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)
- McKesson Corporation (NYSE:MCK ) Annual Evercore ISI HealthCONx Healthcare Conference December 4, 2024 8:20 AM ET Company Participants Britt Vitalone - Executive Vice President and Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore ISI Elizabeth Anderson Thank you for joining us this morning. Appreciate you coming by.
- 12/04/2024
|
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
- Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
- 11/27/2024
|
Why McKesson (MCK) is a Top Value Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 11/26/2024
|
McKesson Stock Gains 34.1% YTD: What's Driving the Rally?
- MCK continues to gain because of robust segmental performance and raised fiscal 2025 guidance.
- 11/21/2024
|
MCK Stock Down Despite Latest Partnership to Boost SCD Treatment
- The availability of the FDA-approved drug via McKesson's cell and gene therapies business is expected to give patients improved treatment options for SCD.
- 11/21/2024
|
All You Need to Know About McKesson (MCK) Rating Upgrade to Buy
- McKesson (MCK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 11/13/2024
|
McKesson (MCK) Is Considered a Good Investment by Brokers: Is That True?
- The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
- 11/13/2024
|
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
- Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
- 11/13/2024
|
Here is Why Growth Investors Should Buy McKesson (MCK) Now
- McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market.
- 11/11/2024
|
Here's Why McKesson (MCK) is a Strong Momentum Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 11/11/2024
|
5 Stocks That Look Promising Following Broker Rating Upgrades
- Investors should monitor stocks like American Airlines, Air Canada, DXC, Dollar General, and McKesson for high returns.
- 11/11/2024
|
McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network
- I reiterate a 'Strong Buy' on McKesson, driven by growth from GLP-1 medications and a robust oncology network business, with a fair value of $696 per share. McKesson's acquisition of a 70% interest in Florida Cancer Specialists enhances its oncology network, expanding to 3,300 providers across 31 states. Strong Q2 results with 21% revenue growth and raised EPS guidance to $32.40-$33.00, driven by specialty distribution and retail national account customers.
- 11/09/2024
|
MCK Stock Gains as Q2 Earnings & Sales Top Estimates, '25 EPS View Up
- McKesson's second-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.
- 11/07/2024
|
These Analysts Boost Their Forecasts On McKesson Following Upbeat Earnings
- McKesson MCK reported better-than-expected second-quarter financial results on Wednesday.
- 11/07/2024
|
McKesson Corporation (MCK) Q2 2025 Earnings Call Transcript
- McKesson Corporation (MCK) Q2 2025 Earnings Call Transcript
- 11/06/2024
|
McKesson (MCK) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
- Although the revenue and EPS for McKesson (MCK) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 11/06/2024
|
McKesson (MCK) Q2 Earnings and Revenues Beat Estimates
- McKesson (MCK) came out with quarterly earnings of $7.07 per share, beating the Zacks Consensus Estimate of $6.89 per share. This compares to earnings of $6.23 per share a year ago.
- 11/06/2024
|
McKesson raises annual profit forecast on strength in its U.S. pharma segment
- Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S. pharmaceuticals segment on robust demand for specialty and branded drugs.
- 11/06/2024
|
McKesson Corporation Reports Fiscal 2025 Second Quarter Results and Raises Full Year Adjusted EPS Guidance
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2025 second quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, November 6th at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live a.
- 11/06/2024
|
Should You Buy, Sell or Hold McKesson Before Q2 Earnings?
- MCK's second-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.
- 11/04/2024
|
Ahead of McKesson (MCK) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
- Beyond analysts' top -and-bottom-line estimates for McKesson (MCK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
- 11/01/2024
|
McKesson Corporation Declares Quarterly Dividend
- IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 71 cents per share of common stock. The dividend will be payable on January 2, 2025, to stockholders of record on December 2, 2024. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufact.
- 10/31/2024
|
McKesson (MCK) Reports Next Week: Wall Street Expects Earnings Growth
- McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/30/2024
|
McKesson (MCK) Beats Stock Market Upswing: What Investors Need to Know
- In the latest trading session, McKesson (MCK) closed at $508.95, marking a +0.3% move from the previous day.
- 10/28/2024
|
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
- McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
- 10/23/2024
|
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 10/21/2024
|
McKesson (MCK) Rises As Market Takes a Dip: Key Facts
- In the latest trading session, McKesson (MCK) closed at $513.67, marking a +0.86% move from the previous day.
- 10/15/2024
|
Is Trending Stock McKesson Corporation (MCK) a Buy Now?
- McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
- 10/10/2024
|
McKesson Corporation: A Defensive Healthcare Value Stock Without A Patent Cliff
- Healthcare is a great defensive sector that has lower amounts of cyclicality than others that depend on the booming economy. With the stock currently down -21.44% off of its all-time high, the stock is giving investors a nice entry point as it reverts to the mean S&P500 returns. The company was the highest-scoring large cap on the most recent Magic Formula screen for October 2024.
- 10/09/2024
|
Prediction: This Will Be the Best-Performing Stock in 2030
- 24/7 Wall St. Insights Selecting stocks for the long haul can be a challenge.
- 10/04/2024
|
McKesson (MCK) Stock Dips While Market Gains: Key Facts
- McKesson (MCK) reachead $488.78 at the closing of the latest trading day, reflecting a -1.95% change compared to its last close.
- 10/02/2024
|
S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- At many points in September, investors heard about the S&P 500 hitting a record high. But at several points in that month, the index pulled back instead of moving higher.
- 10/02/2024
|
Here's Why McKesson (MCK) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 10/02/2024
|
You Should Be Investing in Dividend Growth Stocks. These Are the 2 Best to Buy In October
- While dividend stock investing is one of the best strategies an investor can pursue to create phenomenal wealth, chasing yield can undermine the entire effort.
- 10/02/2024
|
McKesson (MCK) Stock Sinks As Market Gains: Here's Why
- The latest trading day saw McKesson (MCK) settling at $479.06, representing a -0.02% change from its previous close.
- 09/26/2024
|
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
- Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- 09/26/2024
|
Stock Of The Day: Has McKesson Found Its Bottom And Will It Bounce Back?
- The best traders traders focus on key price levels and stock momentum, understanding that oversold stocks at support often experience a rally.
- 09/24/2024
|
McKesson Corporation Announces Second Quarter Fiscal 2025 Earnings Release Date
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2025 financial results after market close on Wednesday, November 6, 2024. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live webcast will be available on McKesson's Investor Relations website at http://investor.mckesson.com, along with the company's earnings release, financial tables and slide pr.
- 09/23/2024
|
4 Stocks to Buy Amid Dental Supplies Industry Challenges
- Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include BDX, MCK, COO and STAA.
- 09/20/2024
|
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
- In the latest trading session, McKesson (MCK) closed at $508.16, marking a -0.68% move from the previous day.
- 09/19/2024
|
Here's Why You Should Retain McKesson Stock in Your Portfolio Now
- MCK's strategic collaborations and strength in Biologics raise optimism about the stock.
- 09/19/2024
|
Why McKesson (MCK) is a Top Value Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 09/16/2024
|
McKesson - Meet The New Dividend Stock On My Watchlist
- McKesson's recent sell-off offers a compelling opportunity, driven by its strong position in healthcare distribution and growing focus on AI and technology for sustainable growth. The company boasts solid revenue and EPS growth, supported by AI integration, expansion into high-demand sectors like GLP-1 and oncology, and a robust business model. Shareholder returns are enhanced by aggressive buyback plans, a 15% dividend hike, and a healthy balance sheet, despite a low 0.6% dividend yield.
- 09/14/2024
|
McKesson (MCK) Exceeds Market Returns: Some Facts to Consider
- McKesson (MCK) reachead $518.81 at the closing of the latest trading day, reflecting a +1.49% change compared to its last close.
- 09/13/2024
|
McKesson (MCK) Rises Yet Lags Behind Market: Some Facts Worth Knowing
- McKesson (MCK) concluded the recent trading session at $511.17, signifying a +0.14% move from its prior day's close.
- 09/12/2024
|
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
- Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- 09/12/2024
|
McKesson, News Corporation And 2 Other Stocks Executives Are Selling
- The Nasdaq 100 closed lower by over 500 points during Friday's session. Investors, meanwhile, focused on some notable insider trades.
- 09/09/2024
|
McKesson Shares Fall Following Sale of Rexall, Well.ca to Birch Hill
- MCK announces the sale of its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, aligning with its strategy to grow oncology and biopharma services.
- 09/06/2024
|
S&P 500 Gains and Losses Today: McKesson Falls Amid Plans To Exit Canada Businesses
- Major U.S. equities indexes were mixed as the latest ADP jobs data showed a smaller-than-expected jump in private payrolls in August.
- 09/05/2024
|
Drug distributor McKesson forecasts Q2 profit below estimates
- Drug distributor McKesson on Thursday forecast second-quarter profit below Wall Street estimates.
- 09/05/2024
|
McKesson Corporation (MCK) Wells Fargo 2024 Healthcare Conference (Transcript)
- McKesson Corporation (NYSE:MCK ) Wells Fargo 2024 Healthcare Conference September 5, 2024 8:45 AM ET Company Participants Britt Vitalone - Executive Vice President and Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Stephen Baxter Good morning. I'm Steve Baxter, the Healthcare Services Analyst at Wells Fargo.
- 09/05/2024
|
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
- Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- 08/29/2024
|
McKesson (MCK) Upgraded to Buy: Here's Why
- McKesson (MCK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 08/28/2024
|
Should Value Investors Buy McKesson (MCK) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 08/28/2024
|
Wall Street Analysts See McKesson (MCK) as a Buy: Should You Invest?
- When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
- 08/28/2024
|
MCK Stock's Uptrend Likely to Continue After Core Ventures Acquisition
- McKesson's agreement to acquire a controlling interest will likely bring advanced treatments and improved care experiences to patients.
- 08/27/2024
|
Drug distributor McKesson to buy controlling stake in Core Ventures for about $2.5 bln
- Drug distributor McKesson said on Monday it would buy a controlling stake in community cancer center Florida Cancer Specialists & Research Institute's business and administrative services unit, Core Ventures, for $2.49 billion in cash.
- 08/26/2024
|
McKesson to acquire controlling stake in Core Ventures for $2.49 billion in cash
- McKesson Corp. MCK, -1.56% said Monday it has agreed to acquire a controlling stake in Community Oncology Revitalization Enterprise Ventures, LLC , or Core Ventures, a physician-owned community oncology practice to about $2.49 billion in cash. Once the deal closes, Core Ventures will become part of McKesson's oncology network.
- 08/26/2024
|
14 Upcoming Dividend Increases Including 2 Kings
- Fourteen upcoming dividend increases, including two Dividend Kings: Nordson Corp with a 14.7% increase and Dover Corp with a 1% increase. New challengers Cactus Inc. and Murphy USA join the list with 5-year dividend growth streaks. People's Financial Services Corp offers a significant 50% dividend increase.
- 08/22/2024
|
McKesson (MCK) Stock Gains 18% YTD: What's Driving the Rally?
- McKesson's (MCK) shares rally on the back of solid fundamentals. Increasing volumes of prescription and specialty drugs boost the top line.
- 08/19/2024
|
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
- Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
- 08/15/2024
|
3 Healthcare Stocks to Sell in August Before They Crash & Burn
- The stock market is currently in a rotation. Traders are moving capital from aggressive growth and technology names to find safety in other sectors of the market.
- 08/09/2024
|
McKesson Revenue Hurt by Supply and Demand Issues for Weight-Loss Drugs
- McKesson (MCK) shares tumbled Thursday, a day after the healthcare services provider warned that limited supply of GLP-1 weight-loss drugs is hurting sales.
- 08/08/2024
|
McKesson (MCK) Q1 Earnings Beat Estimates, Revenues Up Y/Y
- McKesson's (MCK) first-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.
- 08/08/2024
|
McKesson Reports Weak Sales, Joins JFrog, Fastly, Warner Bros. Discovery And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
- U.S. stock futures were mixed this morning, with the Dow futures falling around 0.2% on Thursday.
- 08/08/2024
|
McKesson (MCK) Reports Q1 Earnings: What Key Metrics Have to Say
- Although the revenue and EPS for McKesson (MCK) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 08/07/2024
|
McKesson (MCK) Tops Q1 Earnings Estimates
- McKesson (MCK) came out with quarterly earnings of $7.88 per share, beating the Zacks Consensus Estimate of $7.16 per share. This compares to earnings of $7.27 per share a year ago.
- 08/07/2024
|
McKesson misses quarterly revenue as U.S. pharmaceutical segment weighs
- McKesson Corp reported weaker-than-expected first-quarter revenue on Wednesday due to soft demand for branded and specialty drugs that dragged sales down in its U.S. pharmaceuticals segment.
- 08/07/2024
|
3 Healthcare Stocks Positioned for Possible Market Outperformance
- So far in 2024, healthcare stocks have run into periodic earnings challenges compared to historical first quarters. For example, quarterly earnings for healthcare stocks across the board were down 25% compared to first-quarter 2023 earnings.
- 08/07/2024
|
Here's Why McKesson (MCK) is a Strong Momentum Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 08/07/2024
|
Should You Buy, Sell or Hold McKesson (MCK) Before Q1 Earnings?
- McKesson's (MCK) first-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.
- 08/05/2024
|
Unlocking Q1 Potential of McKesson (MCK): Exploring Wall Street Estimates for Key Metrics
- Beyond analysts' top -and-bottom-line estimates for McKesson (MCK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.
- 08/02/2024
|
McKesson (MCK) Advances While Market Declines: Some Information for Investors
- McKesson (MCK) reachead $629.09 at the closing of the latest trading day, reflecting a +1.96% change compared to its last close.
- 08/01/2024
|
McKesson (MCK) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/31/2024
|
Healthy Profits: 7 Healthcare Stocks to Build a Lifetime of Wealth
- There are a whole host of reasons to invest in healthcare stocks over the long term. The United States has an aging population.
- 07/30/2024
|
McKesson (MCK) Increases Yet Falls Behind Market: What Investors Need to Know
- In the latest trading session, McKesson (MCK) closed at $600.16, marking a +0.74% move from the previous day.
- 07/26/2024
|
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
- McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 07/25/2024
|
McKesson (MCK) Increases Despite Market Slip: Here's What You Need to Know
- McKesson (MCK) closed at $585.74 in the latest trading session, marking a +0.47% move from the prior day.
- 07/23/2024
|
McKesson (MCK) Gains 26% Year to Date: What's Backing the Rally?
- McKesson's (MCK) shares have risen 1.5% year to date on the back of solid fundamentals. Increasing volumes of prescription and specialty drugs boost the top line.
- 07/17/2024
|
Here's Why McKesson (MCK) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 07/15/2024
|
3 Reasons Why You Should Hold McKesson (MCK) Stock for Now
- McKesson's (MCK) robust Biologics business raises optimism about the stock.
- 07/12/2024
|
McKesson (MCK) Declines More Than Market: Some Information for Investors
- In the latest trading session, McKesson (MCK) closed at $575.23, marking a -1.98% move from the previous day.
- 07/11/2024
|
Here's Why McKesson (MCK) is a Strong Momentum Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 07/11/2024
|
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
- Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
- 07/11/2024
|
Why McKesson (MCK) is a Top Value Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 06/28/2024
|
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
- Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- 06/27/2024
|
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
- In the latest trading session, McKesson (MCK) closed at $599.56, marking a -0.8% move from the previous day.
- 06/26/2024
|
McKesson Corporation Announces First Quarter Fiscal 2025 Earnings Release Date
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2025 financial results after market close on Wednesday, August 7, 2024. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live webcast will be available on McKesson's Investor Relations website at http://investor.mckesson.com, along with the company's earnings release, financial tables and slide prese.
- 06/26/2024
|
Outcomes® Showcased at McKesson ideaShare 2024
- NEW ORLEANS--(BUSINESS WIRE)--Outcomes, a leader in integrated pharmacy workflow and patient engagement solutions, announced that it will feature a new prescription counting solution, Pill Count, at McKesson ideaShare. By leveraging AI and machine learning, Pill Count™ makes counting pills easier and more accurate. This is the latest solution for Outcomes, a company that offers a full suite of patient engagement, clinical and pharmacy workflow solutions across the nation's largest community net.
- 06/24/2024
|
The 3 Healthiest Healthcare Stocks to Buy for a Huge Dose of Profits
- The healthcare sector is often considered a defensive play, with healthcare stocks to buy offering stability and growth potential even during economic downturns. The sector's strength is driven by an aging global population, rising healthcare expenditures, and advancements in medical technology.
- 06/23/2024
|
McKesson (MCK) Reaches 52-Week High: What's Aiding the Stock?
- Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
- 06/21/2024
|
McKesson (MCK) Increases Despite Market Slip: Here's What You Need to Know
- In the most recent trading session, McKesson (MCK) closed at $603.24, indicating a +0.05% shift from the previous trading day.
- 06/20/2024
|
McKesson (MCK) Introduces FDA-Approved Prostate Cancer Drug
- The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients improved treatment options for prostate cancer.
- 06/20/2024
|
McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to Know
- McKesson (MCK) closed at $589.95 in the latest trading session, marking a -0.19% move from the prior day.
- 06/14/2024
|
4 Stocks to Buy Amid Dental Supplies Industry Challenges
- Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include MCK, WST, ALGN and HSIC.
- 06/14/2024
|
McKesson (MCK) Laps the Stock Market: Here's Why
- The latest trading day saw McKesson (MCK) settling at $591.07, representing a +1.07% change from its previous close.
- 06/13/2024
|
Is Trending Stock McKesson Corporation (MCK) a Buy Now?
- Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- 06/13/2024
|
McKesson (MCK) Gains 26% YTD: What's Driving the Rally?
- McKesson's (MCK) shares have risen year to date on the back of strong fundamentals. Rising volumes of prescription and specialty drugs boost the top line.
- 06/13/2024
|
7 Trending Stocks With Momentum on Their Side
- Traders and other investors looking to take short positions in trending stocks with momentum on their side should consider this list. It covers seven equities that have maintained positive trajectories over the past month and in many cases, the entirety of this year and beyond.
- 06/12/2024
|
3 No-Nonsense S&P 500 Stocks to Buy and Hold Forever
- There is no end in sight to the stock market's latest bull run. These S&P 500 stocks keep rising, hitting new all-time highs.
- 06/12/2024
|
McKesson is a Growing Giant
- McKesson Corporation (MCK) is poised to grow due to an aging population and expanding Type 2 diabetes treatments.
- 06/11/2024
|
Here's Why You Should Hold McKesson (MCK) in Your Portfolio Now
- McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
- 06/11/2024
|
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 06/04/2024
|
McKesson's Board of Directors Elects Deborah Dunsire as New Director
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that the McKesson board of directors has elected Dr. Deborah Dunsire as a director and member of the Compensation and Talent Committee and Finance Committee, effective June 3, 2024. “We're pleased to welcome Deborah to the McKesson board,” said Donald Knauss, McKesson's independent board chair. “She is a highly respected healthcare industry leader with a proven track record of leading large, complex organizations a.
- 06/03/2024
|
Bulletproof Your Retirement: 3 Stocks That Will Stand the Test of Time
- In retirement, stability and downside protection are the main investment objectives. You need retirement-proof stocks that guarantee stable growth with minimal volatility to succeed.
- 06/02/2024
|
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
- Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
- 05/31/2024
|
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
- Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
- 05/21/2024
|
Exchange Solutions Unveils Industry-First Generative AI Feature Enablement for a Loyalty Platform
- BOSTON & TORONTO--(BUSINESS WIRE)--Exchange Solutions, a leading provider of personalized loyalty solutions, proudly announces the launch of groundbreaking Generative AI features integrated into its loyalty platform. This innovative advancement, now available for use within the SaaS console, marks a significant milestone in enhancing marketer efficiency and effectiveness in loyalty program management. The newly introduced Generative AI features are designed to empower marketers with enriched loyalty execution capabilities, offering unparalleled convenience and agility. With a focus on optimizing operational workflows, these features include: Shane O'Neil, Chief Technology Officer at Exchange Solutions, commented on the significance of this pioneering initiative, stating, "At Exchange Solutions, we are committed to pushing the boundaries of innovation to deliver unparalleled value to our clients. The incorporation of Generative AI features into our platform represents a transformative leap forward in enhancing marketer efficiency and campaign effectiveness. By leveraging these AI capabilities, we give loyalty program marketers the power to unlock new levels of agility and performance in loyalty analytics, advanced targeting and overall program management supercharging productivity and insights." Exchange Solutions remains dedicated to advancing the frontier of personalized loyalty solutions, with a steadfast commitment to delivering exceptional value and innovation to its clientele. Future Release: Exchange Solutions is excited to announce that the next phase of Generative AI features, focusing on new ways to access loyalty data and member insights, is currently under development. Stay tuned for the upcoming release, which will further elevate the capabilities of the platform in driving actionable insights and maximizing ROI for our clients. About Exchange Solutions Exchange Solutions is a cloud-based loyalty platform management company that delivers personalized loyalty solutions to B2C and B2B businesses, enabling them to build deeper and more profitable engagement with their consumers. With more than 25 years of experience in the industry, Exchange Solutions transforms loyalty programs and promotions from being costly applications to productive and profitable capabilities for clients across various industries in the US and Canada. Current clients include retailers such as Esso™ and Mobil™, Sobeys Inc., McKesson, Indochino, Suncor and White Cap.
- 05/20/2024
|
Here's Why McKesson (MCK) is a Strong Momentum Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 05/17/2024
|
McKesson (MCK) Q4 Earnings Miss Estimates, Revenues Up Y/Y
- McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.
- 05/08/2024
|
McKesson Corporation (MCK) Q4 2024 Earnings Call Transcript
- McKesson Corporation (NYSE:MCK ) Q4 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Rachel Rodriguez - VP of Investor Relations Brian Tyler - Chief Executive Officer Britt Vitalone - Executive Vice President and Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Allen Lutz - Bank of America Merrill Lynch Lisa Gill - JPMorgan Michael Cherny - Leerink Partners Charles Rhyee - TD Cowen Eric Percher - Nephron Research Stephanie Davis - Barclays Elizabeth Anderson - Evercore ISI Daniel Grosslight - Citi Erin Wright - Morgan Stanley Stephen Baxter - Wells Fargo Operator Please stand by. Welcome to McKesson's Fourth Quarter Fiscal 2024 Earnings Conference Call.
- 05/07/2024
|
McKesson (MCK) Reports Q4 Earnings: What Key Metrics Have to Say
- The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 05/07/2024
|
McKesson misses quarterly estimates as US pharmaceuticals segment weighs
- McKesson Corp reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for the company's branded and specialty drugs that dragged sales in its U.S. pharmaceutical segment.
- 05/07/2024
|
McKesson (MCK) Q4 Earnings and Revenues Lag Estimates
- McKesson (MCK) came out with quarterly earnings of $6.18 per share, missing the Zacks Consensus Estimate of $6.34 per share. This compares to earnings of $7.19 per share a year ago.
- 05/07/2024
|
McKesson Corporation Reports Fiscal 2024 Fourth Quarter and Full Year Results
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2024 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Tuesday, May 7th at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and arch.
- 05/07/2024
|
Here's Why McKesson (MCK) is a Strong Value Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 05/07/2024
|
Seeking Clues to McKesson (MCK) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
- Looking beyond Wall Street's top -and-bottom-line estimate forecasts for McKesson (MCK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
- 05/02/2024
|
Earnings Preview: McKesson (MCK) Q4 Earnings Expected to Decline
- McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/30/2024
|
McKesson (MCK) Rises But Trails Market: What Investors Should Know
- In the closing of the recent trading day, McKesson (MCK) stood at $543.30, denoting a +0.62% change from the preceding trading day.
- 04/26/2024
|
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 04/26/2024
|
9 Stocks That Thrive When Interest Rates Are Higher
- Though economic stress could be on the way, a few groups of stocks can benefit.
- 04/25/2024
|
The Top 3 Healthcare Stocks to Buy in April 2024
- Healthcare stocks, especially industry leaders that offer a wide range of products and services, can be an investor's best friend due to the growing need for increased development of healthcare products and services. These stocks tend to provide investors with a substantial return on their investment.
- 04/22/2024
|
Why McKesson (MCK) is a Top Value Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 04/19/2024
|
McKesson Launches Project Oasis to Address Pharmacy Deserts in Underserved Communities
- IRVING, Texas--(BUSINESS WIRE)--McKesson launches Project Oasis, a new initiative aimed at advancing health equity for at-risk populations in underserved communities.
- 04/02/2024
|
Here's Why McKesson (MCK) is a Strong Value Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 04/01/2024
|
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
- Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
- 03/28/2024
|
McKesson Corporation Announces Fourth Quarter Fiscal 2024 Earnings Release Date
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its fourth quarter and full year fiscal 2024 financial results after market close on Tuesday, May 7, 2024. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live webcast will be available on McKesson's Investor Relations website at http://investor.mckesson.com, along with the company's earnings release, financial tables and s.
- 03/27/2024
|
Rite Aid reaches bankruptcy settlement with lenders, DOJ, McKesson
- Pharmacy chain Rite Aid has reached a settlement with its lenders, the U.S. Department of Justice, and drug supplier McKesson Corp , clearing a path for Rite Aid to complete its bankruptcy case by late April, a company lawyer said Tuesday.
- 03/26/2024
|
Here's Why You Should Hold McKesson (MCK) in Your Portfolio
- McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
- 03/22/2024
|
Why McKesson (MCK) is a Top Value Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 03/07/2024
|
Are Investors Undervaluing McKesson (MCK) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 02/28/2024
|
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
- Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
- 02/27/2024
|
Here's Why McKesson (MCK) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 02/20/2024
|
McKesson: GLP-1 Contributed More Than 1/3 Of Growth
- McKesson reported 15% topline growth and 12.2% adjusted EPS growth in their recent earnings report. The company's GLP-1 medications have shown impressive growth, contributing 60% to year-over-year growth. McKesson's strong distribution network and the increasing demand for GLP-1 medications position them for continued growth opportunities.
- 02/19/2024
|
3 Attractive Medical Stocks to Buy After Earnings
- Following their favorable quarterly results this week here are three intriguing healthcare stocks that investors will want to consider.
- 02/08/2024
|
McKesson (MCK) Beats on Q3 Earnings, Raises FY24 EPS View
- McKesson's (MCK) third-quarter fiscal 2024 results benefit from growth in the United States. Divestment hurts the International segment.
- 02/08/2024
|
Here's What Key Metrics Tell Us About McKesson (MCK) Q3 Earnings
- The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 02/07/2024
|
McKesson raises annual profit forecast on strong demand for specialty medicines
- U.S.-based drug distributor McKesson raised its annual profit forecast on Wednesday, banking on strong demand for specialty medicines.
- 02/07/2024
|
5 Dividend Growth Stocks to Buy for a Safe Portfolio
- Installed Building Products (IBP), PACCAR. (PCAR), McKesson (MCK), Republic Services (RSG) and PulteGroup (PHM) seem solid choices for a safe portfolio amid the current market volatility.
- 02/06/2024
|
McKesson Corporation (MCK) Hits Fresh High: Is There Still Room to Run?
- McKesson (MCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 02/05/2024
|
Exploring Analyst Estimates for McKesson (MCK) Q3 Earnings, Beyond Revenue and EPS
- Evaluate the expected performance of McKesson (MCK) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- 02/02/2024
|
McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 01/31/2024
|
Here's Why McKesson (MCK) is a Strong Value Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 01/31/2024
|
3 Hidden Healthcare Stocks Poised for a Breakout This Year
- One of the most important sectors not only in the financial markets but also in everyone's life, is the healthcare sector. It can provide investors with good returns due to its constant growth and continuous development, and the more it grows, the more companies grow along with it.
- 01/30/2024
|
Should Value Investors Buy McKesson (MCK) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 01/25/2024
|
McKesson (MCK) Set to Sell Canadian Rexall Pharmacy Group
- McKesson (MCK) is seeking buyers for the Canadian Rexall Pharmacy Group. The business is currently amid its second round of offers, with no set deadline for submissions.
- 01/19/2024
|
Here's Why You Should Add McKesson (MCK) to Your Portfolio Now
- McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
- 01/17/2024
|
Charts turn bullish on health-care stocks as sector takes early lead in 2024
- Chart-watchers are growing increasingly bullish on health-care stocks now that they have become the best-performing sector of the S&P 500 so far in 2024, according to Dow Jones Market Data. Analysts have cited attractive valuations relative to earnings and a compelling growth story as two reasons health-care stocks might continue to outperform.
- 01/16/2024
|
US drug retailer McKesson seeks buyers for Canada's Rexall Pharmacy -source
- McKesson Corp is planning to sell Canadian drugstore chain Rexall Pharmacy Group, a source familiar with the process told Reuters on Friday, seven years after the U.S. drug distributor bought the business for about C$3 billion ($2.2 billion).
- 01/12/2024
|
Here's Why McKesson (MCK) is a Strong Value Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 01/11/2024
|
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
- Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
- 01/04/2024
|
McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January Conference
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2024 financial results after market close on Wednesday, February 7, 2024. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. McKesson management will be participating in the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024. The live webcast for each event will be available on McKes.
- 12/27/2023
|
Silver Economy Successes: 3 Stocks Benefitting From an Aging Population
- Finding investment opportunities in tune with today's demographic trends can be challenging, but aging population stocks may be the solution. This market is booming in a world with an aging population, creating a special opportunity for investors to profit.
- 12/27/2023
|
McKesson (MCK) Announces Availability of PNH's FDA-Approved Drug
- The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for PNH.
- 12/26/2023
|
Here's Why You Should Retain McKesson (MCK) Stock for Now
- McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
- 12/13/2023
|
McKesson (MCK) Announces Availability of FDA-Approved Drug
- The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for desmoid tumors.
- 12/11/2023
|
McKesson (MCK) Announces Availability of FDA-Cleared Drug
- The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for breast cancer.
- 12/04/2023
|
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
- Medical distributors are seeing increased demand for certain medicines. Drugs for weight loss made by Novo Nordisk and Eli Lilly are what's driving growth.
- 12/04/2023
|
McKesson (MCK) Announces Availability of FDA-Cleared mCRC Drug
- The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for mCRC.
- 11/17/2023
|
3 Biotech Stocks You'll Regret Not Buying Soon: November 2023
- Biotechnology is a booming industry recently focused on synthetic biology, biomanufacturing and gene editing. Biotech is seen as the key to the future, as it has the potential to cure diseases and save many lives.
- 11/14/2023
|
Here's Why You Should Retain McKesson (MCK) Stock for Now
- McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
- 11/13/2023
|
McKesson (MCK) Beats on Q2 Earnings, Raises '23 EPS View
- McKesson's (MCK) second-quarter fiscal 2024 results benefit from growth in the United States. Divestment hurts the International segment.
- 11/02/2023
|
Here's What Key Metrics Tell Us About McKesson (MCK) Q2 Earnings
- While the top- and bottom-line numbers for McKesson (MCK) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 11/01/2023
|
McKesson Corporation (MCK) Q2 2024 Earnings Call Transcript
- McKesson Corporation (NYSE:MCK ) Q2 2024 Earnings Conference Call November 1, 2023 4:30 PM ET Company Participants Rachel Rodriguez - Vice President of Investor Relations Brian Tyler - Chief Executive Officer Britt Vitalone - Executive Vice President and Chief Financial Officer Conference Call Participants Eric Percher - Nephron Research Lisa Gill - JPMorgan Charles Rhyee - Cowen & Company Brian Tanquilut - Jefferies Eric Coldwell - Baird Kevin Caliendo - UBS Daniel Grosslight - Citi Research Allen Lutz - Bank of America Merrill Lynch Erin Wright - Morgan Stanley Elizabeth Anderson - Evercore ISI George Hill - Deutsche Bank Operator Please standby. Welcome to McKesson's Second Quarter Fiscal 2024 Earnings Conference Call.
- 11/01/2023
|
McKesson lifts annual profit forecast after strong quarterly results
- Drug distributor McKesson Corp on Wednesday raised its annual profit forecast, banking on strong demand for specialty medicines.
- 11/01/2023
|
Top 3 Blue-Chip Stocks in the Healthcare Industry
- Blue-chip companies are very well established, have an excellent reputation and boast a history of providing investors with consistent returns. Blue-chip stocks are a must for investors because they are some of the most stable companies in the market and typically have lower volatility than other companies with not-so-stellar reputations.
- 11/01/2023
|
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
- 10/30/2023
|
5 Safe Stocks to Buy Amid Uncertainty on Wall Street
- At this juncture, we have narrowed our search to five stocks from defensive sectors like utilities, consumer staples and healthcare. These stocks are: NJR, LW, MCK, PEP, PG.
- 10/30/2023
|
Buy These 4 Low-Beta Stocks to Counter Market Volatility
- It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Granite Ridge (GRNT), Ardmore Shipping (ASC), McKesson (MCK) and Stride (LRN) are well-poised to gain.
- 10/30/2023
|
Are Investors Undervaluing McKesson (MCK) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 10/25/2023
|
5 Stocks Backed by High Efficiency to Boost Portfolio Returns
- Invest in companies like Toll Brothers (TOL), Universal Display (OLED), Applied Industrial Technologies (AIT), PBF Energy (PBF) and McKesson (MCK) to make the most of their higher efficiency levels.
- 10/25/2023
|
Our Top 10 Picks For Dividend Growth Stocks - October 2023
- We pick high-growth dividend stocks that have rapidly grown their dividends in the recent past rather than offering a high current yield. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. We provide criteria for selecting high-growth dividend stocks, offering a step-by-step guide on structuring a portfolio based on this strategy.
- 10/21/2023
|
Here's Why McKesson (MCK) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 10/20/2023
|
McKesson Aims For The $500 Milestone After Shattering Previous Record Highs And Outperforming The S&P 500! - McKesson (NYSE:MCK)
- McKesson Corp's MCK impressive performance stands out amidst a decline in the S&P 500 index.
- 10/20/2023
|
7 Healthcare Stocks That Can Cure a Lackluster Portfolio
- This hasn't been a great year for healthcare stocks. The Dow Jones U.S. Health Care Index is down 4% on the year compared to a 14% gain in the S&P 500 index.
- 10/19/2023
|
Bankrupt Rite Aid resolves drug supply dispute with McKesson
- Pharmacy chain Rite Aid has settled a critical dispute with drug supplier McKesson Corp to ensure that customers' prescriptions will continue to be filled during Rite Aid's bankruptcy, attorneys said on Tuesday.
- 10/17/2023
|
4 Stocks That Flaunt an Impressive Interest Coverage Ratio
- A company that is capable of generating earnings well above its interest expense can withstand financial hardship. LRN, DECK, MOH and MCK and are sound enough to meet financial obligations.
- 10/16/2023
|
McKesson (MCK) Upgraded to Strong Buy: Here's What You Should Know
- McKesson (MCK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
- 10/12/2023
|
Eli Lilly, McKesson, Novartis Flash Promising Chart Action
- Although healthcare stocks lag other sectors, large-cap leaders such as Eli Lilly & Co. NYSE: LLY, McKesson Corp. NYSE: MCK and Novartis AG NYSE: NVS are in possible buy ranges as they get moving-average support.
- 10/09/2023
|
Manufacturing Data Improves, Bond Yields Stay Elevated
- We got some slightly better September Manufacturing numbers than expected from the final S&P PMI and ISM reports.
- 10/02/2023
|
Why McKesson (MCK) is a Top Value Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 10/02/2023
|
4 Stocks That Stand Out on Attractive Interest Coverage Ratio
- A company that is capable of generating earnings well above its interest expense can withstand financial hardship. MOD, SFM, MOH and MCK are sound enough to meet financial obligations.
- 09/29/2023
|
McKesson Corporation Announces Second Quarter Fiscal 2024 Earnings Release Date
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2024 financial results after market close on Wednesday, November 1, 2023. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live webcast will be available on McKesson's Investor Relations website at http://investor.mckesson.com, along with the company's earnings release, financial tables and slide pr.
- 09/27/2023
|
Dive Into Dividends: Top 5 Bargain Growth Stocks to Buy
- Applied Materials (AMAT), PulteGroup (PHM), Arcos Dorados (ARCO), McKesson (MCK) and NetEase (NTES) could be compelling picks for investors in the current scenario.
- 09/27/2023
|
Is McKesson (MCK) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 09/25/2023
|
5 Low-Beta Stocks to Sail Through a Choppy Market
- Market volatility will stay for a longer time. Invest in socks like American Water Works Company (AWK), PepsiCo (PEP), Vistra Corp. (VST), McKesson Corporation (MCK) and J&J Snack Foods (JJSF).
- 09/25/2023
|
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
- Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
- 09/21/2023
|
5 Cash Cow Stocks to Buy Now
- Procter & Gamble (PG), Amazon (AMZN), Verizon (VZ), McKesson (MCK) and D.R. Horton (DHI) are some of the cash-rich companies that one can invest in.
- 09/19/2023
|
Add These 4 Stocks With Remarkable Interest Coverage Ratio
- A company that is capable of generating earnings well above its interest expense can withstand financial hardship. STRL, SFM, MOH and MCK are sound enough to meet financial obligations.
- 09/13/2023
|
Should Value Investors Buy McKesson (MCK) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 09/08/2023
|
Here's Why McKesson (MCK) is a Strong Value Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 09/07/2023
|
Are Medical Stocks Lagging McKesson (MCK) This Year?
- Here is how McKesson (MCK) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.
- 09/05/2023
|
Bet on These 4 Stocks With Exciting Interest Coverage Ratio
- A company capable of generating earnings well above its interest expense can withstand financial hardship. SFM, MOH, ATO and MCK are strong enough to meet financial obligations.
- 08/29/2023
|
Should Value Investors Buy McKesson (MCK) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 08/23/2023
|
2 Stocks Warren Buffett Is Loving (and One He Let Go)
- Warren Buffett is an investing legend because he's just that good. Since he became CEO of Berkshire Hathaway (NYSE: BRK-A )(NYSE: BRK-B ) in 1965, the Oracle of Omaha generated 3.7 million percent returns for investors.
- 08/22/2023
|
The 7 Most Undervalued Value Stocks to Buy Now: August 2023
- While the glitz and glamour of the hottest technology firms organically command our attention, investors should earmark some time for researching value stocks to buy. Fundamentally, these under-the-radar ideas offer the potential for significant returns.
- 08/17/2023
|
McKesson (MCK) & Genpact Extend Tie Up to Improve Workflow
- McKesson's (MCK) latest partnership extension is likely to transform its finance operations for enhanced service and competitive growth.
- 08/17/2023
|
3 Most Surprising Takeaways from Q2 Earnings Season
- The Q2 earnings season is nearly in the books. As of Aug. 4, 84% of the S&P 500 had reported their results.
- 08/16/2023
|
3 Stocks to Buy on Recent Dividend Hikes
- Dividend hikes reflect a company's commitment to returning value to shareholders, undoubtedly encouraging. And recently, all three of these companies have boosted their payouts.
- 08/14/2023
|
Buffett bet on home builders and retreated from videogames during the second quarter
- Warren Buffett's Berkshire Hathaway Inc. took new stakes in home builders, bulked up on Capital One Financial Corp. and backed away from Activision Blizzard Inc. in the second quarter, according to quarterly disclosures filed on Monday.
- 08/14/2023
|
Warren Buffett's Berkshire Hathaway bet on 3 homebuilders - and sold and slashed a bunch of stocks last quarter
- Warren Buffett's Berkshire Hathaway added a trio of homebuilders to its portfolio last quarter. The investor's company exited three stocks and slashed several of its positions, SEC filings show.
- 08/14/2023
|
McKesson (MCK) Q1 Earnings Beat Estimates, U.S. Sales Strong
- McKesson's (MCK) fiscal first-quarter 2024 results benefit from growth in the United States. Divestment hurts the International segment.
- 08/03/2023
|
McKesson (MCK) Beats Q1 Earnings and Revenue Estimates
- McKesson (MCK) came out with quarterly earnings of $7.27 per share, beating the Zacks Consensus Estimate of $5.85 per share. This compares to earnings of $5.83 per share a year ago.
- 08/02/2023
|
McKesson lifts annual profit forecast after strong quarterly results
- Drug distributer McKesson on Wednesday raised its full-year profit forecast after strong demand for specialty medicines and weight-loss drugs helped the company beat estimates for first-quarter results.
- 08/02/2023
|
McKesson (MCK) to Report Q1 Earnings: Is a Beat in Store?
- McKesson's (MCK) fiscal first-quarter 2024 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.
- 07/31/2023
|
Pick These 4 Stocks With Superb Interest Coverage Ratio
- A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Lincoln Electric (LECO), McKesson (MCK), Atmos Energy (ATO) and O'Reilly (ORLY) are sound enough to meet financial obligations.
- 07/28/2023
|
Magnetar Financial LLC Reduces Stake in MedTech Acquisition Corp
- On July 25, 2023, Magnetar Financial LLC (Trades, Portfolio), a renowned investment firm, reduced its stake in MedTech Acquisition Corp ( MTACU , Financial). This article provides an in-depth analysis of the transaction, the profiles of both the firm and the traded company, and the potential implications for value investors.
- 07/27/2023
|
7 Millionaire-Maker Healthcare Stocks to Buy Before the Window Closes
- Healthcare continues to be a major industry and economic driver around the world. According to the American Medical Association, spending on healthcare in the U.S. totals more than $4 trillion each year, which works out to nearly $13,000 per person.
- 07/27/2023
|
McKesson boosts quarterly dividend 15%
- McKesson Corp. MCK, -1.08% said Monday that it raised its quarterly dividend declared July 21 to $0.62 per share, a 15% increase from $0.54 per share in the prior quarter. “The dividend increase reflects confidence in our strategy and ability to generate sustained strong cash flows,” McKesson CEO Brian Tyler said in a statement.
- 07/24/2023
|
3 Healthcare Stocks Using AI to Deliver You Healthy Profits
- Artificial intelligence ( AI ) is aiming to revolutionize the healthcare sector, forging a new era of medical innovation. As we dive into the realm of the top AI healthcare stocks, it's imperative to understand the game-changing potential of this technology.
- 07/18/2023
|
3 Healthcare Stocks to Buy as the Market Gets Defensive
- With so much concern about the Federal Reserve and its decision-making implications for forward market trends, investors may do well targeting healthcare stocks. Fundamentally, the underlying sector represents a critical need.
- 07/18/2023
|
MCK Stock Participation Minimal, Hence The Exit
- Stocks that stop working don't often get much room in swing trading.
- 07/14/2023
|
Here's Why You Should Add McKesson (MCK) to Your Portfolio
- McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
- 07/11/2023
|
Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report?
- McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/07/2023
|
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
- Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
- 07/03/2023
|
McKesson Corporation Announces First-Quarter Fiscal 2024 Earnings Release Date
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first-quarter fiscal 2024 financial results after market close on Wednesday, August 2, 2023. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live webcast will be available on McKesson's Investor Relations website at http://investor.mckesson.com, along with the company's earnings release, financial tables and slide prese.
- 06/28/2023
|
Why McKesson (MCK) is a Top Value Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 06/28/2023
|
McKesson's (MCK) Latest Launch to Give Access to OTC Products
- McKesson's (MCK) latest launch is expected to meet the evolving needs and growing demand for quality OTC private-label health and wellness products.
- 06/27/2023
|
2 Best Buffett Stocks to Buy for the Long Haul
- McKesson is the largest pharmaceutical distributor in the U.S. Johnson & Johnson is one of the largest healthcare companies in the world. Both stocks have steadily increased their dividends over the years.
- 06/26/2023
|
Here's Why You Should Retain McKesson (MCK) Stock for Now
- McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
- 06/07/2023
|
The 3 Best Healthcare Stocks to Buy for June 2023
- Healthcare stocks have been trailing the market this year. Vanguard's Health Care ETF (NYSEARCA: VHT ) is down 5% on the year, compared with a 10% year-to-date gain in the benchmark S&P 500 index.
- 05/29/2023
|
Worried About a Recession? 2 Safe Stocks to Buy Now
- Pfizer's priorities include investing in its business and rewarding shareholders through dividend growth. McKesson has shifted its focus to its highest-growth and highest-margin businesses.
- 05/24/2023
|
5 Stocks You Can Confidently Invest $500 in Right Now
- Consumers will spend in almost any economy; you just have to offer what they want or need most. IBM may never become the tech powerhouse it once was, but it reliably generates cash.
- 05/19/2023
|
McKesson Stock Approaching New Highs As Bullish Trend Continues
- McKesson Corp. NYSE: MCK is among the elite group of stocks breaking out of bases and approaching new highs. While there have been numerous breakouts recently, many are out of patterns forming well below multi-year highs; McKesson is within striking distance of its highest price ever.
- 05/12/2023
|
McKesson (MCK) Q4 Earnings Beat Estimates, U.S. Sales Strong
- McKesson's (MCK) fiscal fourth-quarter 2023 results benefit from growth in the United States. Divestment hurt the International segment.
- 05/09/2023
|
2 Warren Buffett Stocks to Buy Hand Over Fist in May
- Mastercard and McKesson both have solid growth profiles. They both have increased their dividend payouts.
- 05/09/2023
|
McKesson Corporation (MCK) Q4 2023 Earnings Call Transcript
- McKesson Corporation (NYSE:MCK ) Q4 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants Nicole Kramer - Manager, Investor Relations Brian Tyler - Chief Executive Officer Britt Vitalone - Executive Vice President and Chief Financial Officer Conference Call Participants Eric Percher - Nephron Research Michael Cherny - Bank of America Lisa Gill - JPMorgan Brian Tanquilut - Jefferies Charles Rhyee - TD Cowen Daniel Grosslight - Citi George Hill - Deutsche Bank Kevin Caliendo - UBS Steven Valiquette - Barclays Erin Wright - Morgan Stanley Elizabeth Anderson - Evercore ISI A.J. Rice - Credit Suisse Operator Welcome to McKesson's Fourth Quarter Fiscal 2023 Earnings Conference Call.
- 05/08/2023
|
McKesson (MCK) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
- The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 05/08/2023
|
McKesson (MCK) to Report Q4 Earnings: Is a Beat in Store?
- McKesson's (MCK) fiscal fourth-quarter results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.
- 05/05/2023
|
These Have Been 3 of the Best-Performing Healthcare Stocks Since 2020
- Demand for Moderna's COVID-19 vaccine will taper off this year, but investors remain bullish on its prospects. McKesson is a top distributor of pharmaceuticals and a key cog in the healthcare industry.
- 05/04/2023
|
Worried About a Recession? 2 Resilient Stocks to Buy Now
- Pfizer is early in what should be a busy 18-month period for new treatments and label expansions, with as many as 19 possible by midyear 2024. McKesson should benefit from its focus on two high-growth markets.
- 04/29/2023
|
7 Healthcare Stocks With Huge Return Potential for Long-Term Investors
- Healthcare stocks are one of the best bets out there. The U.S. spends more on healthcare than any other country.
- 04/27/2023
|
Could McKesson Stock Help You Become a Millionaire?
- McKesson is shifting its focus into its highest growth areas: oncology and biopharma services. The company also plans on rewarding investors through dividends and share buybacks.
- 04/27/2023
|
2 Sustainable Growth Stocks to Buy Now for Long-Term Profits
- Holding stocks that consistently grow a bit every year without fail is a good idea. McKesson will continue to grow for as long as the healthcare sector does.
- 04/22/2023
|
Viking Global's Top Five Stock Bets - Amazon.com (NASDAQ:AMZN), Elevance Health (NYSE:ELV)
- Viking Global Investors is an elite hedge fund run by former Tiger Cub Andreas Halvorsen. The Norwegian billionaire has a nearly unparalleled track record of success in the often fickle stock-picking game.
- 04/21/2023
|
2 Best Buffett Stocks to Buy for the Long Haul
- Coca-Cola's revenue climbed despite last-year's tough economic environment. McKesson may be entering a new phase of growth as it focuses on biopharma services and oncology.
- 04/19/2023
|
McKesson Stock: Bear vs. Bull
- McKesson isn't about to explode in value anytime soon. But it'll likely continue to grow at a plodding pace for the next few decades.
- 04/11/2023
|
Here's Why You Should Retain McKesson (MCK) Stock for Now
- McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
- 04/10/2023
|
5 S&P 500 Stocks Showing Strength As Recession Fears Rise
- Medical stocks are holding up amid economic and market uncertainty. The post 5 S&P 500 Stocks Showing Strength As Recession Fears Rise appeared first on Investor's Business Daily.
- 04/07/2023
|
Magic Formula Dividend Portfolio For April
- The following is a dividend portfolio strategy for large caps that score the highest amongst Joel Greenblatt's Magic Formula screener. The list follows large caps that have dividends.
- 04/07/2023
|
2 Top Healthcare Stocks Defying the Bear Market
- The demand for medical product distribution is set to grow and McKesson is the clear leader of the industry. Sanofi's stacked product portfolio and pipeline should power double-digit annual earnings growth.
- 04/07/2023
|
Is It Too Late to Buy McKesson Stock?
- McKesson has had 10 consecutive years of annual revenue increases. It has increased its dividend for 15 consecutive years, including double-digit boosts the past two years.
- 03/22/2023
|
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
- Stock market investors have been on a rollercoaster ride over the past year. The Federal Reserve continues to be hawkish in controlling inflation.
- 03/21/2023
|
Even Warren Buffett Loses Billions On 4 Bank Stocks
- The banking crisis is costing most S&P 500 investors serious money. Even Warren Buffett is taking his lumps.
- 03/17/2023
|
McKesson Stock: Bull vs Bear
- McKesson has divested most of its European businesses and is focusing on its highest-growth areas. The healthcare company's growth isn't impressive, and its COVID-19 tailwind is fading.
- 03/11/2023
|
Here's Why You Should Retain McKesson (MCK) Stock Right Now
- McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
- 03/10/2023
|
McKesson Corporation Is A Stable Long-Term Addition
- McKesson Corporation has a strong position in the industry, and with a strong last quarterly performance, the current share price seems to offer a good entry point. There are many tailwinds for the company, but a major one is again US population where people will need the services more and for longer.
- 03/10/2023
|
All You Need to Know About McKesson (MCK) Rating Upgrade to Buy
- McKesson (MCK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 03/08/2023
|
Is McKesson a Buy?
- McKesson's stock has significantly outperformed the S&P 500 over the past five years.
- 03/03/2023
|
5 Smart Beta Dividend Stocks to Buy Now for Steady Gains
- Hershey (HSY), ParkerHannifin (PH), The Interpublic Group (IPG), Microchip Technology (MCHP), and McKesson (MCK) could be solid choices for your portfolio amid rising yields.
- 03/02/2023
|
Warren Buffett Just Sold Shares of This Company. Should You?
- McKesson has offered investors safety and growth.
- 03/01/2023
|
After Plunging -7.62% in 4 Weeks, Here's Why the Trend Might Reverse for McKesson (MCK)
- The heavy selling pressure might have exhausted for McKesson (MCK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- 03/01/2023
|
3 Reasons Why Growth Investors Shouldn't Overlook McKesson (MCK)
- McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 02/20/2023
|
2 Best Buffett Stocks to Buy for the Long Haul
- Warren Buffett is known for picking great businesses.
- 02/19/2023
|
Is This Warren Buffett Stock a Buy for Dividend Growth Investors?
- This Buffett-backed business leads the medical distribution industry.
- 02/16/2023
|
McKesson (MCK) Announces Availability of FDA-Cleared Drug for MCL
- The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for MCL.
- 02/15/2023
|
Warren Buffett Didn't Buy a Single New Stock to End 2022. But He Cut From 8.
- Buffett's company Berkshire Hathaway spent more time selling stocks than buying in the fourth quarter of 2022.
- 02/14/2023
|
3 Highly-Ranked Stocks that Beat the Market in 2022 to Buy Now
- Digging into three highly-ranked stocks that outperformed the market in 2022 amid the turmoil and are primed to keep running higher in 2023 even if Wall Street is forced to take its foot off the growth pedal.
- 02/10/2023
|
Here's Why McKesson (MCK) is Poised for a Turnaround After Losing -6.24% in 4 Weeks
- The heavy selling pressure might have exhausted for McKesson (MCK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- 02/07/2023
|
Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"
- McKesson (MCK) could produce exceptional returns because of its solid growth attributes.
- 02/03/2023
|
5 Dental Supplies Stocks to Buy Amid Recovering Prospects
- Here, we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors - MCK, ABC, LH, CAH and MMSI.
- 02/03/2023
|
McKesson (MCK) Q3 Earnings Surpass Estimates, EPS View Up
- McKesson's (MCK) third-quarter fiscal 2023 results benefit from segmental growth.
- 02/02/2023
|
McKesson Corporation (MCK) Q3 2023 Earnings Call Transcript
- McKesson Corporation (NYSE:MCK ) Q3 2023 Results Conference Call February 1, 2023 4:30 PM ET Company Participants Rachel Rodriguez - VP, IR Brian Tyler - CEO Britt Vitalone - CFO Conference Call Participants Michael Cherny - Bank of America Merrill Lynch Lisa Gill - JPMorgan Eric Percher - Nephron Research Charles Rhyee - Cowen George Hill - Deutsche Bank Steven Valiquette - Barclays Brian Tanquilut - Jefferies LLC A.J. Rice - Credit Suisse Operator Welcome to McKesson's Third Quarter Fiscal 2023 Earnings Conference Call.
- 02/01/2023
|
McKesson (MCK) Tops Q3 Earnings and Revenue Estimates
- McKesson (MCK) delivered earnings and revenue surprises of 8.83% and 0.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/01/2023
|
Are Medical Stocks Lagging McKesson (MCK) This Year?
- Here is how McKesson (MCK) and Annovis Bio, Inc. (ANVS) have performed compared to their sector so far this year.
- 02/01/2023
|
2 Medical Stocks to Consider Buying Before Earnings
- There is a continued need for prosperous healthcare companies, here are two medical stocks investors may want to consider buying ahead of earnings this week.
- 01/30/2023
|
McKesson (MCK) to Report Q3 Earnings: Is a Beat in the Cards?
- McKesson's (MCK) fiscal third-quarter results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.
- 01/27/2023
|
2 Best Buffett Stocks to Buy for the Long Haul
- You won't ever want to sell these solid long-term favorites.
- 01/23/2023
|
5 Warren Buffett Stocks to Buy Hand Over Fist in 2023
- These stocks deliver a lot of the elements Buffett loves most.
- 01/18/2023
|
3 Top Healthcare Stocks to Buy for January
- These healthcare stocks have a lot going for them in the new year.
- 01/11/2023
|
4 Stocks Trading Near 52-Week High That Can Scale Higher
- Investors target stocks that have been on a bullish run lately. Stocks like HRI, DCP, MRC and MCK that are seeing price strength have a high chance of carrying the momentum forward.
- 01/10/2023
|
Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?
- Here is how McKesson (MCK) and Doctor Reddy's (RDY) have performed compared to their sector so far this year.
- 01/09/2023
|
My Favorite Warren Buffett Stocks for 2023
- These Buffett stocks look like a bargain you won't want to miss.
- 01/06/2023
|
Jim Cramer predicts these ten S&P 500 stocks will perform well in 2023
- Cramer named 10 stocks listed in the S&P 500 that he believes could perform well this year.
- 01/04/2023
|
These were Warren Buffett's 10 best performing stocks held by Berkshire Hathaway in 2022
- Some of the best performers have been owned by Buffett for decades, like Coca-Cola, while others are new additions to the portfolio, like T-Mobile.
- 01/04/2023
|
McKesson (MCK) Flat As Market Sinks: What You Should Know
- In the latest trading session, McKesson (MCK) closed at $375.12, marking no change from the previous day.
- 12/30/2022
|
Are Investors Undervaluing McKesson (MCK) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 12/29/2022
|
3 Stocks to Sell Ahead of a Recession in 2023
- If you are an investor looking for stocks to sell before a recession next year, you'll most likely be hitting the mark. While 2022 has been an alarming year for stocks due to rampant inflation and rate hikes, with most tech and cyclical stocks facing massive selloffs, many stocks are still long overdue for a correction.
- 12/29/2022
|
McKesson Corporation Announces Third-Quarter Fiscal 2023 Earnings Release Date
- IRVING, Texas--( BUSINESS WIRE )--McKesson Corporation (NYSE: MCK) will release its third-quarter fiscal 2023 financial results after market close on Wednesday, February 1, 2023. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
- 12/28/2022
|
5 Reasons Why I Am Considering Adding McKesson To My Portfolio
- Despite a steadily climbing share price in 2022, McKesson Corporation remains attractively undervalued. McKesson's dividend, while comparatively small, is well-covered and fast-growing.
- 12/27/2022
|
Here's Why You Should Retain McKesson (MCK) Stock Right Now
- McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
- 12/27/2022
|
Top Fund's Stocks For Profiting Amid 2023 Market Uncertainty, Stagflation
- Want to know how to invest in stocks, now and in 2023? The hot Muhlenkamp Fund carefully picks stocks and aims to profit amid stagflation.
- 12/27/2022
|
Buy This Warren Buffett-Owned Stock for 2023 and Beyond
- This healthcare products distributor's business model can withstand a recession.
- 12/26/2022
|
McKesson (MCK) Announces Availability of FDA-Accepted Drug
- The availability of FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for PEComa.
- 12/23/2022
|
Warren Buffett Bought 19 Stocks in 2022; These 3 Are the Best Bets for 2023
- All three of these Buffett stocks have trounced the market this year.
- 12/20/2022
|
All You Need to Know About McKesson (MCK) Rating Upgrade to Buy
- McKesson (MCK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 12/15/2022
|
7 New Stocks Warren Buffett Bought in 2022
- Buffett's company Berkshire Hathaway didn't sit around this year.
- 12/15/2022
|
Have $1,000? 2 Warren Buffett Stocks to Buy
- End the year on a Buffett-inspired note.
- 12/14/2022
|
McKesson Corporation: Still Trading Below Intrinsic Value
- McKesson reported solid second quarter results. Not only is the business recession-resilient, it also settled the opioid litigations in 2022.
- 12/13/2022
|
3 Non-Energy S&P 500 Stocks With Enough Energy to Boost Returns
- Though energy companies have been among the best-performing stocks in the S&P 500 index, here we discuss some top-performing non-energy S&P 500 stocks like MRK, VRTX and MCK.
- 12/12/2022
|
3 Defense Stocks To Watch In The Stock Market Now
- Are these the top defense stocks to invest in right now?
- 12/05/2022
|
3 Stocks Silently Outperforming Energy in 2022
- Outperforming the Zacks Oils and Energy sector in 2022 is no easy task. However, bulls have silently roamed in all three of these stocks, breaking the overall bearish trend we've become accustomed to.
- 12/01/2022
|
McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why
- McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market.
- 11/29/2022
|
Is This Healthcare Giant a Buy for Dividend Growth Investors?
- Berkshire Hathaway has a 2.3% stake in this healthcare stock.
- 11/28/2022
|
5 Solid Dividend Growth Stocks for Thanksgiving
- Archer-Daniels-Midland (ADM), McKesson (MCK), ParkerHannifin (PH), Booz Allen Hamilton (BAH) and Darden Restaurants (DRI) could be compelling picks for your portfolio this Thanksgiving.
- 11/23/2022
|
Should Value Investors Buy McKesson (MCK) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 11/22/2022
|
Buy These 5 Corporate Giants Flying High in Disappointing 2022
- We have narrowed our search to five U.S. corporate behemoths that have popped year to date. These are: ADM, MPC, XOM, MRK and MCK.
- 11/22/2022
|
Warren Buffett Likes This Passive Income Stock
- McKesson has many of the hallmarks of the type of stable company Berkshire Hathaway likes to own.
- 11/21/2022
|
Warren Buffett Makes All His Money From Just 11 Stocks
- Warren Buffett is having a much better year than most S&P 500 investors. And he can thank a handful of stocks for that.
- 11/18/2022
|
3 Underrated Warren Buffett Stocks That Are Smart Buys Right Now
- These Berkshire Hathaway-owned stocks all have major tailwinds to propel them higher in the years to come.
- 11/18/2022
|
October CPI Data Raises Hope for a Soft Landing: 5 Top Picks
- We have narrowed our search to five U.S. corporate behemoths with solid growth potential. These are: HUM, MPC, CAT, MCK and ORLY.
- 11/11/2022
|
3 Dental Supplies Stocks to Watch Amid Industry Headwinds
- Here we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors - BDX, MCK and ABC.
- 11/09/2022
|
3 Reasons Growth Investors Will Love McKesson (MCK)
- McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market.
- 11/08/2022
|
Invest Like Warren Buffett With These 3 Stocks
- Many investors mimic Warren Buffett, closely following all of his moves. And with his track record of success, it's easy to see why.
- 11/07/2022
|
Bear Market Investing: Should You Buy Today's Top Performers?
- Some stocks are defying the bear market.
- 11/03/2022
|
McKesson Corporation (MCK) Q2 2023 Earnings Call Transcript
- McKesson Corporation (NYSE:MCK ) Q2 2023 Earnings Conference Call November 1, 2022 4:30 PM ET Company Participants Rachel Rodriguez - VP, IR Brian Tyler - CEO Britt Vitalone - CFO Conference Call Participants Eric Percher - Nephron Research Michael Cherny - Bank of America Merrill Lynch Lisa Gill - JPMorgan Steven Valiquette - Barclays Charles Rhyee - Cowen Kevin Caliendo - UBS George Hill - Deutsche Bank Brian Tanquilut - Jefferies LLC AJ Rice - Credit Suisse Liz Anderson - Evercore ISI Erin Wright - Morgan Stanley Operator Welcome to McKesson's Second Quarter Fiscal 2023 Earnings Conference Call. Please be advised that today's conference is being recorded.
- 11/01/2022
|
McKesson (MCK) Lags Q2 Earnings Estimates
- McKesson (MCK) delivered earnings and revenue surprises of -1.14% and 0.71%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/01/2022
|
Drug Behemoth McKesson Calls For Greater-Than-Expected Covid Windfall
- McKesson increased its earnings outlook for the year Tuesday despite lagging quarterly sales and earnings forecasts. The post Drug Behemoth McKesson Calls For Greater-Than-Expected Covid Windfall appeared first on Investor's Business Daily.
- 11/01/2022
|
Top 5 Stocks Set to Beat on Earnings After Markets Close
- Five companies will report earnings results today after the closing bell. These are: CHK, MCK, ENLC, LTHM and ZI.
- 11/01/2022
|
Why Earnings Season Could Be Great for McKesson (MCK)
- McKesson (MCK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 10/31/2022
|
The 7 Best Boring Stocks to Buy for Red-Hot Returns
- Everyone defines “boring stocks” differently, and everyone has their own ideas about criteria for the best boring stocks. For example, I consider Mexican cement producer Cemex to be an incredibly dull stock.
- 10/31/2022
|
Pick These 4 Stocks With Excellent Interest Coverage Ratio
- A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Companies such as Heritage-Crystal (HCCI), Cadence (CDNS), McKesson (MCK) and Schlumberger (SLB) are capable of meeting financial obligations.
- 10/27/2022
|
3 Top-Ranked Medical Stocks Lapping the S&P 500
- All three stocks are up double-digit percentages in 2022, leaving the S&P 500's performance in the dust. With the stocks carrying favorable near-term earnings outlooks, the run could easily continue.
- 10/25/2022
|
McKesson (MCK) to Report Q2 Earnings: Is a Beat in the Cards?
- McKesson's (MCK) fiscal second-quarter results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.
- 10/25/2022
|
Warren Buffett's Buying This Passive Income Stock: Should You?
- McKesson delivered share price gains and passive income so far this year.
- 10/25/2022
|
S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength
- S&P 500 giant Vertex and Cheniere Energy, the largest U.S. liquefied natural gas producer, are setting up bullishly in the bear market. The post S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength appeared first on Investor's Business Daily.
- 10/22/2022
|
Is This Buffett-Backed Blue Chip Stock a Buy?
- Berkshire Hathaway increased its stake in this healthcare stock by 9.5% in the second quarter.
- 10/22/2022
|
5 Solid Dividend Growth Stocks for Q4
- Boise Cascade (BCC), RCI Hospitality (RICK), Iron Mountain (IRM), McKesson (MCK) and National Fuel Gas (NFG) seem compelling picks for Q4 amid volatility.
- 10/21/2022
|
Should Investors Consider These 3 Warren Buffett Purchases?
- Many people turn to the Oracle of Omaha when looking for stocks to add. After all, it's easy to understand why after seeing his track record.
- 10/20/2022
|
Grab These Top 4 Defensive Stocks to Beat the Market Doldrums
- Here we mention four defensive stocks, namely Lamb Weston (LW), Consolidated Water (CWCO), Archer Daniels Midland (ADM) and McKesson (MCK) with strong prospects to beat the market volatility.
- 10/18/2022
|
7 Warren Buffett Stocks to Buy and Hold for the Next Decade
- Warren Buffet's philosophy relies on identifying stocks to buy and hold. He believes that the best names to buy and hold are those of undervalued companies that have high chances of being successful over the long term.
- 10/17/2022
|
3 Stocks to Add to Your Portfolio in the Market Downturn
- All three companies have easily surpassed the S&P 500 average this year.
- 10/15/2022
|
Recession Stocks: Finding Winners In A Down Stock Market
- Not all stocks are impacted equally by the economy slowing down. We look at stocks that have been winners during a down stock market thus far in 2022 while most of the rest of the market has fallen.
- 10/15/2022
|
These Are The Top 10 Holdings Of Larry Robbins
- Larry Robbins is the founder and CEO of Glenview Capital Management, which is a New York-based hedge fund.
- 10/11/2022
|
4 Defensive Bets to Pacify Pessimists to Ride Market Storms
- Here we mention four defensive stocks, namely Lamb Weston (LW), Consolidated Water, McKesson and Hershey with strong prospects to stay afloat in the bear market.
- 10/11/2022
|
Warren Buffett's Buying This Passive Income Stock
- You should have this blue chip healthcare stock on your radar.
- 10/08/2022
|
3 Top-Ranked Healthcare Stocks Thriving in 2022
- Healthcare stocks generally carry a defensive nature, helping to shield investors from the market's volatility. Demand for the services these companies provide won't be going anywhere anytime soon.
- 10/05/2022
|
2 Stocks Beating the Bear Market
- These healthcare giants benefit from industry trends.
- 10/04/2022
|
3 Stocks With Upgraded Broker Ratings for Impressive Returns
- As brokers have a deeper understanding of stocks, one must follow rating upgrades before investing. We select Hyatt Hotels (H), McKesson (MCK) and Carlsberg (CABGY) as these have seen rating upgrades recently.
- 09/28/2022
|
3 Defensive Stocks To Watch Before October 2022
- Could now be the time to buy these defensive stocks as the stock market hits fresh new 52-week lows today.
- 09/27/2022
|
4 Top-Ranked Defensive Stocks to Buy Amid Market Swings
- Here we mention four defensive stocks, namely Corteva (CTVA), Atmos Energy, National Fuel Gas Company and McKesson with strong prospects to beat the market whims.
- 09/26/2022
|
S&P 500 Giant Leads 5 Stocks Showing Strength In Bear Market
- S&P 500 giant Eli Lilly leads five medical stocks setting up and showing relative strength in the ongoing bear market. The post S&P 500 Giant Leads 5 Stocks Showing Strength In Bear Market appeared first on Investor's Business Daily.
- 09/24/2022
|
3 Medical Stocks Displaying Remarkable Relative Strength in 2022
- In addition to favorable price action, all three carry a strong growth profile, making them appear even more enticing.
- 09/23/2022
|
Here's Why You Should Buy McKesson (MCK) Stock Right Now
- McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
- 09/22/2022
|
Bet on These 5 Ultra-Defensive Stocks for the Rest of 2022
- We have narrowed our search to five low-beta high-yielding defensive stocks that have strong potential for the rest of 2022. These are: NEE, SO, PEP, CTVA and MCK.
- 09/22/2022
|
McKesson (MCK) Stock Pares Gains Following Rx Savings Buyout
- McKesson (MCK) agrees to buy privately-held Rx Savings Solutions in alignment with its strategic plan of creating accessible and affordable treatment options.
- 09/21/2022
|
Defense Wins Ballgames; 3 Blue-Chip Stocks To Consider
- Due to their well-established nature and track records of success, these companies are positioned to weather a dark fiscal cloud better than most.
- 09/19/2022
|
Beat the Market Vagaries With 4 Top-Ranked Defensive Bets
- Grab these four defensive stocks, namely Corteva (CTVA), Hershey (HSY), National Fuel Gas Company (NFG) and McKesson (MCK), which hold strong potential.
- 09/19/2022
|
McKesson to acquire Rx Savings Solutions for up to $875 million
- McKesson Corp. MCK, +1.53% said Monday it has reached an agreement to acquire Rx Savings Solutions for up to $875 million. Rx Savings Solutions is a prescription price transparency and benefit information company that serves about 17 million patients.
- 09/19/2022
|
Relative Strength Wasn't Enough For MCK Stock
- Relative strength helps find winners when markets turn. But don't forget about this element to protect yourself from losses.
- 09/16/2022
|
Are Investors Undervaluing McKesson (MCK) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 09/16/2022
|
5 Dividend Growth Stocks to Buy Cheap
- Boise Cascade (BCC), Triton International (TRTN), TotalEnergies (TTE), McKesson (MCK) and RCI Hospitality (RICK) seem compelling cheap picks amid volatility.
- 09/15/2022
|
5 Broker-Friendly Stocks to Watch as Inflation Stays Red Hot
- Broker-favorite stocks like American Airlines (AAL), CVR Energy (CVI), Builders FirstSource (BLDR), McKesson (MCK) and Beacon Roofing Supply (BECN) should be on investors' watch list amid flared-up inflation.
- 09/15/2022
|
3 Stocks to Add to Your Portfolio in a Market Pullback
- These companies have been strong performers and they could perform very well in your portfolio, too.
- 09/15/2022
|
3 Top Healthcare Stocks Defying the Bear Market
- There's reason to favor these stocks -- and hold on for the long term.
- 09/15/2022
|
3 defensive stocks to buy for the second half of 2022
- The inflation data released on September 13 spooked markets as the S&P 500 and other constituents sold off.
- 09/15/2022
|
These Are Ronald Muhlenkamp's Top 10 Holdings
- Ronald Muhlenkamp is the founder and president of Muhlenkamp & Company, which was established in 1997 to manage private accounts for individuals and institutions.
- 09/14/2022
|
Stay Safe With 5 Defensive Stocks in an Extremely Volatile 2022
- We have narrowed our search to five defensive stocks with growth potential for the rest of 2022. These are: NEE, SO, ADM, PEP, MCK.
- 09/14/2022
|
3 Stocks With Upgraded Broker Ratings for Robust Returns
- As brokers have a deeper understanding of stocks, one must follow rating upgrades before investing. We select BJ, MCK and CRS as these have seen rating upgrades recently.
- 09/13/2022
|
Here is Why Growth Investors Should Buy McKesson (MCK) Now
- McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 09/12/2022
|
3 Stocks to Buy If They Take a Dip
- They're certainly the right stocks, but this isn't quite the right time to buy them.
- 09/08/2022
|
Invest Like Warren Buffett With These 3 Stocks
- The Oracle of Omaha has been on the offensive in 2022, recognizing value in a challenging market.
- 09/06/2022
|
S&P 500 Likely to Trade Rangebound in September: 5 Picks
- We have narrowed our search to five S&P 500 stocks that have popped year to date despite the index's bloodbath. These are: ADM, CTVA, MCK, MPC and XOM.
- 09/06/2022
|
5 Dividend Growth Stocks to Beat September Slump
- Dividend growth stocks like TotalEnergies, J.B. Hunt, Archer-Daniels-Midland, McKesson and Republic Services seem like solid choices for September.
- 08/31/2022
|
This Stock Is Warren Buffett's Best 2022 Buy
- The Oracle of Omaha has added a bunch of stocks that have lost value lately, but this one is standing out with its performance.
- 08/28/2022
|
Is McKesson (MCK) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 08/26/2022
|
10 Stocks (Not In The Energy Sector) Are Up 30% Or More This Year
- It's been almost all about energy stocks in the S&P 500 this year. But not entirely.
- 08/26/2022
|
Here's Why You Should Buy McKesson (MCK) Stock Right Now
- McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
- 08/23/2022
|
Warren Buffett Boldly Loads Up On 4 Of His Best Stocks
- Warren Buffett likes to talk about buying more S&P 500 stocks when they're cheaper. But it turns out he's human, too.
- 08/23/2022
|
Andreas Halvorsen Dumps Comcast, Buys McKesson and AIG
- Viking Global leader Andreas Halvorsen (Trades, Portfolio) disclosed his portfolio for the second quarter of 2022 earlier this week.
- 08/19/2022
|
3 Defensive Stocks To Watch In August 2022
- Should investors be watching these defensive stocks this week?
- 08/16/2022
|
Dividend Growth Investing in Vogue: 5 Stock Picks
- Top-ranked dividend stocks like TotalEnergies (TTE), ArcBest (ARCB), Dollar General (DG), McKesson (MCK) and Archer-Daniels-Midland (ADM) are worth adding to your portfolio.
- 08/16/2022
|
This Indestructible Buffett Stock Is Soaring, But Is It a Buy?
- You might need to have a good deal of patience if you invest.
- 08/15/2022
|
10 defensive stocks that can also provide you with growth and dividends over the long term
- The S&P 500 Index has rallied 10% since June 22 from a deep decline, but there are different schools of thought about whether investors are out of the woods yet.
- 08/10/2022
|
3 Warren Buffett Stocks to Buy That Have Soared 31% to 104% This Year
- Are these high-flying Buffett stocks still smart picks to buy now?
- 08/08/2022
|
3 Reasons Why McKesson Could Be An Attractive Play During A Downturn
- We expect MCK to outperform the broader market in the near term, as the demand for its products and services is relatively independent of consumer sentiment. Most of the firm's revenues are generated by the U.S. pharmaceutical segment, reducing the potential foreign exchange headwinds for the company.
- 08/05/2022
|
McKesson Corporation's (MCK) CEO Brian Tyler on Q1 2023 Results - Earnings Call Transcript
- McKesson Corporation (NYSE:MCK ) Q1 2023 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Rachel Rodriguez – Vice President of Investor Relations Brian Tyler – Chief Executive Officer Britt Vitalone – Chief Financial Officer Conference Call Participants Lisa Gill – J.P. Morgan Michael Cherny – Bank of America Steven Valiquette – Barclays Eric Percher – Nephron Research Ricky Goldwasser – Morgan Stanley Kevin Caliendo – UBS Eric Coldwell – Baird Charles Rhyee – Cowen Brian Tanquilut – Jefferies Operator Please stand by.
- 08/03/2022
|
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
- Here is how McKesson (MCK) and argenex SE (ARGX) have performed compared to their sector so far this year.
- 08/03/2022
|
3 No-Brainer Warren Buffett Stocks That Will Undeniably Profit from the Bear Market
- These unstoppable companies can succeed in pretty much any economic condition.
- 07/27/2022
|
McKesson raises quarterly dividend by 15% to 54 cents a share from 47 cents
- McKesson Corp. MCK, +0.80% said Monday its board has raised its quarterly dividend by 15% to 54 cents a share from 47 cents previously. The new dividend is payable Oct. 3 to shareholders of record as of Sept.
- 07/25/2022
|
7 Best Cash Cow Stocks to Buy for Stable Returns
- Investors seeking shelter from the market selloff through 2022 can take a look at some of the best cash cow stocks to buy. The post 7 Best Cash Cow Stocks to Buy for Stable Returns appeared first on InvestorPlace.
- 07/24/2022
|
Ron Muhlenkamp's Firm Goes on Selling Spree in 2nd Quarter
- Muhlenkamp & Co. Inc., the investment firm founded by Ronald Muhlenkamp (Trades, Portfolio) in 1977, released its equity portfolio for the second quarter earlier this week.
- 07/20/2022
|
3 Medical Device Stocks With Potential to Fight Recession Risk
- The decline in U.S. GDP during the first quarter and 26% decline in the S&P 500 Index so far this year fuel the risk of a recession. MCK, PDCO & AMN have the potential to help investors ward off volatility risks going forward.
- 07/20/2022
|
McKesson Is Still An Attractive Dividend Growth Stock
- McKesson is the leading drug distributor in the United States with operations across the globe. Shares of McKesson has outperformed the market in 2022.
- 07/10/2022
|
Here's Why You Should Retain McKesson (MCK) Stock Right Now
- McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
- 07/05/2022
|
Final Trades: Cleveland-Cliffs, Mckesson & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 06/30/2022
|
10 Warren Buffett Stocks to Buy for the Second Half of 2022
- Warren Buffett is one of the most successful investors in the world, so identifying Warren Buffett stocks is an important trait. The post 10 Warren Buffett Stocks to Buy for the Second Half of 2022 appeared first on InvestorPlace.
- 06/30/2022
|
McKesson Corporation Announces First Quarter Fiscal 2023 Earnings Release Date
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2023 financial results after market close on Wednesday, August 3, 2022. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live webcast will be available on McKesson's Investor Relations website at http://investor.mckesson.com, along with the company's earnings press release, financial tables and slide
- 06/29/2022
|
5 Stocks to Seek Refuge in Amid Current Market Bloodbath
- For significant returns, investors should keep broker-friendly stocks like American Airlines (AAL), PBF Energy (PBF), McKesson Corporation (MCK), Commercial Metals (CMC) and American Axle (AXL) on their radar.
- 06/27/2022
|
7 Warren Buffett Stocks to Buy for a Bear Market
- Faced with sharp losses in equities, investors may be best served following the Warren Buffett stocks to buy for a bear market. The post 7 Warren Buffett Stocks to Buy for a Bear Market appeared first on InvestorPlace.
- 06/27/2022
|
Warren Buffett Just Bought 8 New Stocks: Here's the Best of the Bunch
- This value stock is far more compelling than you might think.
- 06/25/2022
|
McKesson's (MCK) Latest JV to Boost Cancer Treatment Options
- McKesson's (MCK) latest activities in the oncology care space is expected to serve a wider patient pool.
- 06/24/2022
|
These 9 Warren Buffett Stocks Are Higher During the Nasdaq Bear Market
- What bear market? These profitable, time-tested stocks are up by as much as 92% in 2022.
- 06/24/2022
|
McKesson, HCA Healthcare to form JV to increase access to cancer research, clinical trials
- McKesson Corp. MCK, +0.54% and HCA Healthcare Inc. HCA, +1.56% announced Thursday an agreement to form a joint venture to advance cancer care and boost access to oncology research. As part of the agreement, McKesson's U.S. Oncology Research (USOR) and HCA's Sarah Cannon Research Institute (SCRI) will combine to form a oncology research organization aimed at accelerating drug development and increasing availability and access to clinical trials.
- 06/23/2022
|
3 Top Warren Buffett Stocks to Buy in This Bear Market
- Their businesses are built for times like these.
- 06/23/2022
|
McKesson: Best Of Breed In Drug Distributor Oligopoly
- McKesson's value proposition is best of the breed in the healthcare distributor oligopoly. Yields are modest, but fundamentals are strong.
- 06/20/2022
|
3 Warren Buffett Stocks to Buy That Are Practically Inflation-Proof
- These stocks could protect your investment portfolio from high inflation -- just like they're doing for Buffett.
- 06/17/2022
|
Here Are All 16 Stocks Warren Buffett Has Bought Since 2022 Began
- The Oracle of Omaha has put more than $50 billion to work this year.
- 06/15/2022
|
McKesson: Still Profitable Without COVID-19 Boosts
- Management estimates a limited tailwind from its COVID-19-related revenue but nonetheless manages to comfort investors with its sustained diluted EPS that is substantially higher than its FY2021 and FY2020. Despite today's unfavorable market conditions, management remains optimistic on the demand environment.
- 06/04/2022
|
Top 5 Trades of Larry Robbins' Firm in the 1st Quarter
- Glenview Capital Management, the firm founded by Larry Robbins (Trades, Portfolio), disclosed in a regulatory filing that its top five trades during the first quarter included boosts to its holdings of Fiserv Inc. ( FISV , Financial), Cigna Corp. ( CI , Financial) and US Foods Holding Corp. ( USFD , Financial) and reductions to its positions in McKesson Corp. ( MCK , Financial) and Bausch Health Companies Inc. ( BHC , Financial).
- 06/02/2022
|
Here's Why You Should Retain McKesson (MCK) Stock Right Now
- McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
- 06/02/2022
|
Warren Buffett Just Bought 8 New Stocks: Here's the Best of the Bunch
- Two of the legendary investor's recent purchases especially stand out.
- 05/24/2022
|
Warren Buffett's Best Stocks of 2022 So Far: Are They Buys Now?
- Two of the three are new positions for Berkshire Hathaway.
- 05/19/2022
|
3 Stocks Up 25% to 65% That Are Still Smart Buys
- These high-flying stocks could continue soaring.
- 05/18/2022
|
Here's Every Stock Warren Buffett Bought or Sold in the First Quarter
- The Oracle of Omaha was very active in the markets.
- 05/17/2022
|
7 Stock Picks to Play the Post-Pandemic Return of Dental Visits
- Although Covid-19 allowed people the excuse to not see their dentist, the necessary return could benefit these dental stocks to buy. The post 7 Stock Picks to Play the Post-Pandemic Return of Dental Visits appeared first on InvestorPlace.
- 05/09/2022
|
Why McKesson Shares Are Jumping Today
- McKesson Corp (NYSE: MCK) reported Q4 FY22 adjusted EPS of $5.83, +15% Y/Y, and missing the consensus of $6.04. Revenues increased 12% Y/Y to $66.10 billion, surpassing the consensus of $63.61 billion.
- 05/06/2022
|
McKesson (MCK) Q4 Earnings Miss, Revenues Beat Estimates
- McKesson's (MCK) fiscal fourth-quarter 2022 results benefit from segmental growth.
- 05/06/2022
|
McKesson (MCK) Lags Q4 Earnings Estimates
- McKesson (MCK) delivered earnings and revenue surprises of -3.80% and 3.74%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/05/2022
|
Medical Product Stocks' Earnings May 5 Roster: MCK, CAH & PODD
- The Medical Product companies' quarterly results are likely to reflect base business recovery. Let's see how MCK, CAH and PODD are poised ahead of their earnings releases.
- 05/04/2022
|
McKesson (MCK) Earnings Expected to Grow: Should You Buy?
- McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/28/2022
|
McKesson (MCK) Hits 52-Week High: What's Aiding the Stock?
- Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
- 04/18/2022
|
Top 5 S&P 500 Stock Picks To Buy Now
- Investible ETFs that passively reflect the S&P 500 hold immense concentration. The top ten companies in the S&P 500 make up approximately 30% of the overall index.
- 04/11/2022
|
McKesson: Market Is Catching On, Is This The Perfect Stock Right Now?
- McKesson is a leader in the health care industry with moderate growth and relative immunity to economic conditions; it's still underappreciated by the market.
- 04/09/2022
|
10 Stocks That Have Moved Over 20% Since The Indices Lost Over 12%!
- The start of 2022 saw a decline in the stock market. For seasoned investors, this was not unexpected, as corrections in the market are commonplace from January through to March.
- 04/08/2022
|
Bet on These 4 Low-Beta, High-Dividend MedTech Stocks for 2022
- Stocks like Becton, Dickinson and Company (BDX), Phibro Animal Health (PAHC), McKesson Corporation (MCK) and UnitedHealth Group Inc (UNH) are right picks with strong fundamentals.
- 04/08/2022
|
5 Dividend Growth Stocks for Safe Income Amid Volatility
- The Kroger (KR), NVIDIA (NVDA), Jones Lang LaSalle (JLL), Paychex (PAYX) and McKesson (MCK) could be compelling picks amid market volatility.
- 04/07/2022
|
3 Lucrative Stocks From the Promising Dental Supplies Industry
- Despite the COVID-19 pandemic-induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.
- 03/29/2022
|
McKesson (MCK) Soars to 52-Week High, Time to Cash Out?
- McKesson (MCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 03/28/2022
|
McKesson: Stock Keeps Rising
- 100% technical buy signals.
- 03/28/2022
|
Should Value Investors Consider McKesson (MCK) Stock Now?
- Let's see if McKesson (MCK) stock is a good choice for value-oriented investors right now from multiple angles.
- 03/23/2022
|
McKesson (MCK) Is Up 6.34% in One Week: What You Should Know
- Does McKesson (MCK) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 03/22/2022
|
Here's Why You Should Buy McKesson (MCK) Stock Right Now
- McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
- 03/17/2022
|
McKesson (MCK) Hits 52-Week High: What's Aiding the Stock?
- Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
- 03/14/2022
|
U.S. should review drugmakers' opioid settlement tax breaks - House panel
- The U.S. Justice and Treasury Departments should review the tax deductions four drugmakers made related to their $26 billion opioid settlement, the U.S. House Oversight and Reform Committee said in a statement on Monday.
- 03/14/2022
|
McKesson (MCK) Up 5.1% Since Q3 Earnings: What's Driving It?
- Investors are optimistic about McKesson's (MCK) robust segmental performance and raised earnings outlook for fiscal 2022.
- 03/02/2022
|
McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why
- McKesson (MCK) could produce exceptional returns because of its solid growth attributes.
- 02/28/2022
|
Which ETFs Should Investors Be Watching Now? Our Favorite Is The IBB
- Which ETFs Should Investors Be Watching Now? Our Favorite Is The IBB
- 02/15/2022
|
S&P 500 Stocks With Strong Momentum
- We identified 18 stocks in S&P 500 with strong momentum based on our criteria. Ten of the stocks we identified made new all-time highs.
- 02/13/2022
|
3 Reasons Why McKesson (MCK) Is a Great Growth Stock
- McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 02/11/2022
|
Surging Earnings Estimates Signal Upside for McKesson (MCK) Stock
- McKesson (MCK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 02/09/2022
|
The Stock-Picking Puzzle: Putting The Pieces Together
- The Stock-Picking Puzzle: Putting The Pieces Together
- 02/07/2022
|
McKesson (MCK) Stock: Why The Price Increased
- The stock price of McKesson (NYSE: MCK) increased by 3.47% in the most recent trading session. This is why it happened.
- 02/04/2022
|
McKesson Q3 Earnings Beat Street View, Raises FY22 Outlook Boosted By COVID-19 Vaccine Demand
- McKesson Corp MCK reported third-quarter FY22 adjusted EPS of $6.15, +34% Y/Y, and easily beating the analyst consensus of $5.42. Thousands of new traders are learning the ins and outs on how to find profitable trades every day with Benzinga Trading School.
- 02/03/2022
|
McKesson Corporation (MCK) CEO Brian Tyler on Q3 2022 Results - Earnings Call Transcript
- McKesson Corporation (MCK) CEO Brian Tyler on Q3 2022 Results - Earnings Call Transcript
- 02/02/2022
|
McKesson (MCK) Q3 Earnings and Revenues Top Estimates
- McKesson (MCK) delivered earnings and revenue surprises of 14.31% and 3.18%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 02/02/2022
|
Drug distributor McKesson seen getting likely boost from COVID vaccine demand
- McKesson Corp is expected to report strong earnings on Wednesday as an Omicron-driven surge in demand for COVID-19 vaccines and tests is likely to insulate the drug distributor from tepid sales of other medical products.
- 02/02/2022
|
Medical Products Stock Earnings on Feb 2: BSX, TMO & More
- Medical Products companies' Q4 results are likely to reflect an increase in COVID-19 testing demand. Let's see how BSX, TMO, HOLX and MCK are poised ahead of their earnings releases.
- 02/01/2022
|
McKesson (MCK) Hits 52-Week High: What's Aiding the Stock?
- Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
- 01/31/2022
|
McKesson: It's Time To Consider Buying This SWAN Stock
- McKesson: It's Time To Consider Buying This SWAN Stock
- 01/30/2022
|
McKesson (MCK) Gains As Market Dips: What You Should Know
- McKesson (MCK) closed at $246.97 in the latest trading session, marking a +0.55% move from the prior day.
- 01/26/2022
|
7 Low Labor-Cost Stocks to Buy for Solid Margins in 2022
- These seven low-labor-cost stocks -- including Apple and PayPal -- are buys as the U.S. labor market tightens and wages rise in 2022. The post 7 Low Labor-Cost Stocks to Buy for Solid Margins in 2022 appeared first on InvestorPlace.
- 01/21/2022
|
Here is Why Growth Investors Should Buy McKesson (MCK) Now
- McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 01/19/2022
|
3 Stocks Trading With Low Price-to-Free Cash Flow Ratios
- To increase your chances of discovering value opportunities, one method is to screen the market for stocks with lower trailing 12-month price-to-free cash flow ratios than that of the S&P 500 Index, which stands at around 13.47 as of the time of writing.
- 01/14/2022
|
Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report?
- McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/07/2022
|
3 Reasons Growth Investors Will Love McKesson (MCK)
- McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 01/03/2022
|
3 Reasons to Add McKesson (MCK) Stock to Your Portfolio
- Investors continue to be optimistic about McKesson (MCK) owing to its robust Biologics business.
- 12/31/2021
|
McKesson Corporation Announces Third Quarter Fiscal 2022 Earnings Release Date and Participation in January Conference
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2022 financial results after market close on Wednesday, February 2, 2022. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. Additionally, McKesson management will be participating in the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022. The live webcast for each event, and a comp
- 12/29/2021
|
McKesson (MCK) Hits 52-Week High, Can the Run Continue?
- McKesson (MCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 12/28/2021
|
McKesson (MCK) Hits 52-Week High: What's Aiding the Stock?
- Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
- 12/13/2021
|
McKesson (MCK) Upgraded to Strong Buy: Here's What You Should Know
- McKesson (MCK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 12/13/2021
|
Best Growth Stocks to Buy for December 13th
- ARCB, CSV, and MCK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 13, 2021.
- 12/13/2021
|
Best Value Stocks to Buy for December 13th
- ABG, TPH, and MCK made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 13, 2021.
- 12/13/2021
|
McKesson (MCK) Soars to 52-Week High, Time to Cash Out?
- McKesson (MCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 12/09/2021
|
McKesson (MCK) Down 1% Since Last Earnings Report: Can It Rebound?
- McKesson (MCK) reported earnings 30 days ago. What's next for the stock?
- 12/01/2021
|
McKesson (MCK) Stock: $270 Price Target From Argus
- The shares of McKesson Corporation (NYSE: MCK) have received a $270 price target from Argus. These are the details.
- 11/25/2021
|
Are Investors Undervaluing These Medical Stocks Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 11/23/2021
|
3 Promising Stocks From the Buoyant Dental Supplies Industry
- Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.
- 11/23/2021
|
McKesson (MCK) Soars to 52-Week High, Time to Cash Out?
- McKesson (MCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 11/22/2021
|
McKesson, Cardinal Health, AmerisourceBergen Face $95B Opioid Trial In Washington: Reuters
- A Washington state trial against McKesson Corporation (NYSE: MCK), Cardinal Health Inc (NYSE: CAH), and AmerisourceBergen Corp (NYSE: ABC) for the U.S. opioid epidemic is slated to kick off today, Reuters reported. Washington Attorney General Bob Ferguson declined to join a $26 billion nationwide settlement and has accused the drug distributors of creating a public nuisance by failing to prevent the diversion of prescription pills into illegal channels.
- 11/15/2021
|
McKesson, drug distributors face $95 billion opioid trial in Washington state
- A trial pitting Washington state against McKesson Corp and two other drug distributors accused of fueling the U.S. opioid epidemic is slated to kick off on Monday, after the state's attorney general declined to join a $26 billion nationwide settlement.
- 11/15/2021
|
McKesson: Oncology Should Drive Higher Margins And Valuation
- McKesson: Oncology Should Drive Higher Margins And Valuation
- 11/14/2021
|
Surging Earnings Estimates Signal Upside for McKesson (MCK) Stock
- McKesson (MCK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 11/08/2021
|
McKesson Posts Better Than Expected Q2 Earnings; Raises FY22 EPS Outlook Again
- McKesson Corp (NYSE: MCK) reported second-quarter FY22 adjusted EPS of $6.15, +28% Y/Y, and easily beating the analyst consensus of $4.66. Revenues increased 9% Y/Y to $66.57 billion, surpassing the consensus of $63.12 billion, driven by growth in the U.S. Pharmaceutical segment, primarily due to increased specialty volumes and market growth, partially offset by branded to generic conversions.
- 11/02/2021
|
McKesson Corporation (MCK) Q2 CEO Brian Tyler on 2022 Results - Earnings Call Transcript
- McKesson Corporation (MCK) Q2 CEO Brian Tyler on 2022 Results - Earnings Call Transcript
- 11/01/2021
|
Hunting For Bargains Again: 9 Picks
- Hunting For Bargains Again: 9 Picks
- 11/01/2021
|
McKesson (MCK) to Report Q2 Earnings: What's in the Cards?
- McKesson's (MCK) fiscal second-quarter results are likely to reflect the solid show by the U.S. Pharmaceutical and Specialty Solutions segment.
- 10/25/2021
|
McKesson: Deeply Undervalued Despite $7.9 Billion Settlement
- McKesson reported solid quarterly results and is also expecting high growth rates for fiscal 2022 (according to the company's guidance). The company undeniably played a role in the opioid crisis and will have to pay $7.9 billion over the next 18 years.
- 10/22/2021
|
4 Low Price-to-Median-Price-Sales Value Stocks
- When screening the market for bargains, investors may want to consider the following four companies, as their stocks have low price-to-median-price-sales values when compared to the average of the S&P 500 (which stands at around 1.66 as of the writing of this article).
- 10/01/2021
|
Drug Distributors Ink First Opioid Settlement With Cherokee Nation
- Cardinal Health Inc (NYSE: CAH), McKesson Corporation (NYSE: MCK), and AmerisourceBergen Corp (NYSE: ABC), accused of U.S. addiction crisis, have struck a settlement with a tribal government, Reuters reports. As part of the deal with Cherokee Nation's territory in Oklahoma, the three companies will pay $75 million over six and half years to resolve claims linked to the opioid epidemic in the region.
- 09/28/2021
|
McKesson Corporation to Announce Second Quarter Fiscal 2022 Results on November 1, 2021
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2022 financial results after market close on Monday, November 1, 2021. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live webcast will be available on McKesson's Investor Relations website at http://investor.mckesson.com, along with the company's earnings press release, financial tables, and slid
- 09/27/2021
|
Making Sense of the Q3 Earnings Picture and Beyond
- Recent updates on the revisions trends have been somewhat disconcerting, as you can see in the chart below that tracks the evolution of Q3 earnings growth expectations.
- 09/24/2021
|
Distributors Announce Proposed Opioid Settlement Will Proceed to Next Phase
- CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that, under the previously announced proposed settlement agreement and process designed to resolve the opioid claims of state and local governmental entities, they have determined that enough states have agreed to settle to proceed to the next phase. Under the proposed settlement agreement and process, all U.S. States, territories
- 09/04/2021
|
Here's Why You Should Retain McKesson (MCK) Stock Right Now
- McKesson (MCK) continues to benefit from its robust Distribution Solutions segment.
- 08/31/2021
|
21 Upcoming Dividend Increases Including 1 Dividend King
- All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 10.3% and a median increase of 6.7%.
- 08/26/2021
|
McKesson to Host Investor Day on December 8, 2021
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) today announced that the Company will host an Investor Day on December 8, 2021 in New York City. A live audio webcast and presentation slides will be available on McKesson's Investor Relations website at http://investor.mckesson.com. Further details will be provided at a later date. About McKesson Corporation McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology
- 08/16/2021
|
McKesson Is Up 73% But Set To Soar Even More
- The market is 29% overvalued and full of crazy speculative bubbles.
- 08/13/2021
|
Dividend Increases: July 24-30, 2021
- This weekly article series covers dividend changes. A table with relevant data and key statistics of dividend increases is provided.
- 08/09/2021
|
McKesson (MCK) Earnings and Revenues Beat Estimates in Q1
- McKesson's (MCK) fiscal first-quarter 2022 results benefit from strong performance across all segments.
- 08/05/2021
|
McKesson Q1 Earnings Surpass Wall Street Estimate; Raises FY22 EPS Outlook
- McKesson Corp (NYSE: MCK) reported first-quarter FY22 adjusted EPS of $5.56, almost doubled from $2.77 a year ago, and easily beating the analyst consensus of $4.17. Revenues increased 13% Y/Y to $62.67 billion, surpassing the consensus of $59.9 billion, driven by higher volumes from retail national account customers and market growth, partially offset by branded to generic conversions.
- 08/05/2021
|
McKesson Corporation (MCK) CEO Brian Tyler on Q1 2022 Results - Earnings Call Transcript
- McKesson Corporation (MCK) CEO Brian Tyler on Q1 2022 Results - Earnings Call Transcript
- 08/04/2021
|
McKesson (MCK) Q1 Earnings and Revenues Surpass Estimates
- McKesson (MCK) delivered earnings and revenue surprises of 35.94% and 5.16%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 08/04/2021
|
Recap: McKesson Q1 Earnings
- Shares of McKesson (NYSE:MCK) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 100.72% year over year to $5.56, which beat the estimate of $4.17.
- 08/04/2021
|
Is a Surprise Coming for McKesson (MCK) This Earnings Season?
- McKesson (MCK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 08/03/2021
|
McKesson (MCK) to Report Q1 Earnings: What's in the Offing?
- McKesson's (MCK) fiscal first-quarter results are likely to reflect solid show by U.S. Pharmaceutical and Specialty Solutions segment.
- 07/30/2021
|
5 Stocks to Play Low Interest Rates—While They Last
- These companies could borrow money at lower rates and use the proceeds to buy back stock—making their shares more attractive to investors.
- 07/22/2021
|
US States Get $26B Settlement Deal in Opioid Abuse Litigation
- Attorney generals of several states reach settlement deal with J&J (JNJ) and three drug distributors - MCK, CAH and ABC - related to thousands of opioid abuse litigations. Non-participating states may join the deal soon.
- 07/22/2021
|
States announce $26 billion settlement to resolve opioid lawsuits: RPT
- Chris Meekins, Healthcare Policy Research Analyst at Raymond James, joins Yahoo Finance's Kristin Myers and Alexis Christoforous to discuss healthcare talks in Washington this week and the latest news on the opioid lawsuits.
- 07/21/2021
|
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
- What did the stock market do today? It began to address the opioid crisis, it tuned in on Bitcoin and it saw a devastating Olympics loss.
- 07/21/2021
|
Distributors Announce Proposed Opioid Settlement Agreement
- CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have negotiated a comprehensive proposed settlement agreement which, if all conditions are satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities. While the companies strongly dispute the allegations made in these lawsuits, they believe the pr
- 07/21/2021
|
McKesson (MCK) Soars 3.2%: Is Further Upside Left in the Stock?
- McKesson (MCK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- 07/21/2021
|
Drug distributors settle New York opioid claims for up to $1.18 bln
- NEW YORK, July 20 (Reuters) - The three largest U.S. drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nationwide opioid epidemic, the state's attorney general said on Tuesday.
- 07/20/2021
|
McKesson, Cardinal Health, AmerisourceBergen stocks surge after $1.1 billion opioid settlement with NY AG
- Shares of McKesson Corp. , Cardinal Health Inc. and AmerisourceBergen Corp. all surged more than 4% in morning trading Tuesday, after the New York Attorney General Letitia James announced a $1.1 billion settlement agreement with the drug distributors to combat the opioid epidemic. James said the agreement resolves claims for the companies' role in helping fuel the epidemic, and will remove the companies from the ongoing opioid trial.
- 07/20/2021
|
3 Stocks to Tap the Promising Dental Supplies Industry
- Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical-Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.
- 07/15/2021
|
McKesson (MCK) Enters Deal to Divest Some European Businesses
- McKesson (MCK) to sell off some of its European ventures to streamline its business and prioritize investments in areas where it has better expertise.
- 07/09/2021
|
Mckesson Corp Ranked Among Today's Top Buys
- Markets shrugged off concerns this morning and rallied well into the green, with the Dow gaining over 400 points, the S&P 500 gaining just under 1%, and the Nasdaq also in the green. Make the most of it with today's Top Buys from Q.ai's artificial intelligence.
- 07/09/2021
|
Here's Why You Should Retain McKesson (MCK) Stock Right Now
- McKesson (MCK) continues to benefit from its robust Distribution Solutions segment.
- 07/07/2021
|
McKesson Corporation to Announce First Quarter Fiscal 2022 Results on August 4, 2021
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2022 financial results after market close on Wednesday, August 4, 2021. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live webcast will be available on McKesson's Investor Relations website at http://investor.mckesson.com, along with the company's earnings press release, financial tables and slide
- 06/30/2021
|
New York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid
- Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Endo International Plc (NASDAQ: ENDP), and AbbVie Inc's (NYSE: ABBV) Allergan misleadingly marketed opioid drugs as having a low addiction risk, a lawyer for a New York county told jurors, urging them to hold the companies liable. Jayne Conroy, representing Suffolk County, also said that the drug distributors - AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH), and McKesson Corp (NYSE: MCK) failed to report suspicious opioid orders as required.
- 06/29/2021
|
Why Drug Distributors Like McKesson Offer Investors A Haven For 'Stability'
- Some of the biggest coronavirus stocks are names many investors have never heard of. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.
- 06/21/2021
|
McKesson Is Too Cheap To Ignore And Set To Soar
- McKesson is a moat-worthy company with significant advantages of scale, and continues to perform well in the current environment. It continues its track record of robust shareholder returns, and has growth avenues in its oncology program.
- 06/16/2021
|
10 Best Stocks to Buy That Will Get You Through the Day
- If you're looking for stocks to buy, sometimes it pays off to consider the brands you use daily and can't live without. The post 10 Best Stocks to Buy That Will Get You Through the Day appeared first on InvestorPlace.
- 06/10/2021
|
Larry Robbins' Firm Doubles NewHold Investment Position
- Larry Robbins (Trades, Portfolio)'s Glenview Capital Management has revealed an addition to its NewHold Investment Corp. ( NHIC , Financial) holding according to GuruFocus' Real-Time Picks, a Premium feature.
- 06/07/2021
|
Here's Why You Should Retain McKesson (MCK) Stock Right Now
- McKesson (MCK) continues to benefit from its robust Distribution Solutions segment.
- 06/07/2021
|
Pharmacy stocks tumble on report Amazon is weighing a push into physical pharmacies (AMZN, CVS, RAD, WAG, CAH, MCK, ABC)
- Shares of drug retailers including Walgreens Boots Alliance and CVS dropped on Wednesday, as Amazon was reported to be looking at options to set up physical pharmacy locations in the US. Talks at Amazon about setting up standalone pharmacies are mostly exploratory and there are no firm plans to open physical locations, three people familiar with the matter told Insider. Such a move would be part of a plan by the online retail behemoth to earn a larger share of the country's $370 billion prescription drug market.
- 05/26/2021
|
Forget Gold. These 2 High-Yielding Stocks Are Better Inflation Hedges
- Forget Gold. These 2 High-Yielding Stocks Are Better Inflation Hedges
- 05/20/2021
|
Strength Seen in McKesson (MCK): Can Its 6.8% Jump Turn into More Strength?
- McKesson (MCK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- 05/10/2021
|
McKesson Shares Move Higher After Strong FY22 Guidance, Goldman Sachs Price Target Hike
- McKesson Corporation (NYSE: MCK) reported fourth-quarter FY21 EPS of $5.05, which beat the analyst consensus estimate of $5.04 versus $4.27 a year ago. Sales increased 1% Y/Y to $59.14 billion, which missed the analyst consensus estimate of $61.09 billion.
- 05/07/2021
|
McKesson (MCK) Q4 Earnings Beat Estimates, Revenues Miss
- McKesson's (MCK) fiscal fourth-quarter 2021 results benefit from strong performance at Medical-Surgical Solutions segment.
- 05/07/2021
|
5 Stocks To Watch For May 7, 2021
- Some of the stocks that may grab investor focus today are: Wall Street expects Cigna Corp (NYSE: CI) to report quarterly earnings at $4.38 per share on revenue of $40.24 billion before the opening bell. Cigna shares rose 0.5% to $258.25 in after-hours trading.
- 05/07/2021
|
McKesson Corporation (MCK) CEO Brian Tyler on Q4 2021 Results - Earnings Call Transcript
- McKesson Corporation (MCK) CEO Brian Tyler on Q4 2021 Results - Earnings Call Transcript
- 05/06/2021
|
McKesson (MCK) Q4 Earnings Top Estimates
- McKesson (MCK) delivered earnings and revenue surprises of 0.60% and -2.91%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 05/06/2021
|
5 Stocks To Watch For May 6, 2021
- Some of the stocks that may grab investor focus today are: Moderna Inc (NASDAQ: MRNA) reported the effectiveness of its COVID-19 vaccine against variants in an internal study. The company is also expected to report quarterly earnings at $2.39 per share on revenue of $2.04 billion before the opening bell.
- 05/06/2021
|
McKesson (MCK) to Report Q4 Earnings: What's in the Offing?
- McKesson's (MCK) fiscal fourth-quarter results are likely to reflect solid show by U.S. Pharmaceutical and Specialty Solutions segment.
- 04/30/2021
|
Dental Market Shows Strength Despite Pandemic: 3 Stocks to Watch
- Let's keep a watch on three lucrative stocks, XRAY, MCK and MMSI, in the dental space that have performed impressively despite the pandemic-led volatility.
- 04/15/2021
|
Here's Why You Should Hold on to McKesson (MCK) Stock Now
- McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.
- 04/12/2021
|
McKesson: An Undervalued Gem, In A Frothy Market
- McKesson is a mission-critical player in the healthcare supply chain, and is executing well in the current environment. It should see continued near-term growth from the distribution of COVID vaccines, and could see long-term growth from its Ontada technology.
- 04/04/2021
|
McKesson Corporation to Announce Fourth Quarter Fiscal 2021 Results on May 6, 2021
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2021 financial results after market close on Thursday, May 6, 2021. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live webcast will be available on McKesson's Investor Relations website at http://investor.mckesson.com, along with the company's earnings press release, financial tables and slide pr
- 04/01/2021
|
3 Low Forward Price-Earnings Ratio Stock Picks
- Investors may want to consider the following securities as their forward price-earnings ratios are lower than the S&P 500's historical average of 15. The projections of future earnings are based on data from Morningstar analysts.
- 04/01/2021
|
3 Beaten-Down MedTech Stocks to Scoop Up Amid the Pandemic
- Here are some dirt-cheap MedTech value stocks - IVC, MCK, HRC - which are expected to provide long-term gains in 2021.
- 04/01/2021
|
4 Lucrative MedTech Stocks to Bet On in 2021 Amid Pandemic
- Grab these four top stocks, HRC, OMI, MCK and VIVO, which continue to show promise amid the pandemic and can turn out to be wise investment choices for 2021.
- 04/01/2021
|
A Very Strong Q1 and 2021 Earnings Picture
- A Very Strong Q1 and 2021 Earnings Picture
- 03/26/2021
|
Are Investors Undervaluing McKesson (MCK) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 03/26/2021
|
McKesson (MCK) Hits 52-Week High, Can the Run Continue?
- McKesson (MCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 03/15/2021
|
Here's Why You Should Add McKesson (MCK) to Your Portfolio Now
- McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.
- 03/12/2021
|
3 Stocks to Capitalize on Promising Dental Supplies Industry
- 3 Stocks to Capitalize on Promising Dental Supplies Industry
- 03/10/2021
|
Our Sell Discipline
- A client asked whether there is a difference in our sell discipline between high- and low-growth companies.
- 02/22/2021
|
Should Value Investors Buy McKesson (MCK) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 02/19/2021
|
4 Dental Stocks to Watch on Likely Industry Turnaround
- The dental equipment market seems ready to grow as it continues to recover from the COVID-19 pandemic slump, making it prudent to look at names like Henry Schein (HSIC) and McKesson (MCK)
- 02/18/2021
|
Here's Why You Should Hold on to McKesson (MCK) Stock Now
- McKesson (MCK) continues to benefit from the multi-year strategic growth initiative and strength in the Distribution Solutions segment.
- 02/17/2021
|
McKesson Corporation (MCK) CEO Brian Tyler on Q3 2021 Results - Earnings Call Transcript
- McKesson Corporation (MCK) CEO Brian Tyler on Q3 2021 Results - Earnings Call Transcript
- 02/02/2021
|
Here's Why Investors Liked McKesson's Q3 Results
- The COVID-19 pandemic served as a tailwind for the big healthcare supply chain management company.
- 02/02/2021
|
McKesson (MCK) Earnings and Revenues Beat Estimates in Q3
- McKesson's (MCK) fiscal third-quarter 2021 results benefit from strong performance at Medical-Surgical Solutions segment.
- 02/02/2021
|
McKesson (MCK) Q3 Earnings and Revenues Surpass Estimates
- McKesson (MCK) delivered earnings and revenue surprises of 11.38% and 1.16%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 02/02/2021
|
McKesson swings to net loss on $8 billion opioid charge, but adjusted profit rises above forecasts
- Shares of McKesson Corp. rose 0.7% in premarket trading Tuesday, after the health care supply and retail pharmacy company reported a fiscal third-quarter loss of more than $6 billion as a result of an opioid litigation charge, but adjusted profit and revenue that rose above expectations. The company swung to a net loss for the quarter to Dec. 31 of $6.23 billion, or $39.03 a share, from net income of $191 million, or $1.06 a share, in the year-ago period.
- 02/02/2021
|
Recap: McKesson Q3 Earnings
- Shares of McKesson (NYSE:MCK) decreased 0.1% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 20.73% over the past year to $4.60, which beat the estimate of $4.13.
- 02/02/2021
|
McKesson Reports Fiscal 2021 Third-Quarter Results
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) today reported results for the third quarter ended December 31, 2020. Fiscal 2021 Third-Quarter Result Summary Third-Quarter Year-to-Date ($ in millions, except per share amounts) FY21 FY20 Change FY21 FY20 Change Revenues $ 62,599 $ 59,172 6 % $ 179,086 $ 172,516 4 % Income (loss) from Continuing Operations1 (6,226 ) 191 NM (5,204 ) (109 ) NM Adjusted Earnings1,2 741 68
- 02/02/2021
|
MedTech Stock Earnings on Feb 2: IDXX, MCK & More
- In Q4, MedTech stocks are expected to have gained from month-wise sales rebound in many states and regions. However, international sales might have been dampened.
- 02/01/2021
|
The InvestorPlace Q&A: Embrace the Food Revolution With the ANEW ETF
- The ANEW ETF is investing in companies pushing the boundaries of technology when it comes to feeding the planet. Here's what you need to know.
- 01/29/2021
|
McKesson Declares Quarterly Dividend
- IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE: MCK) yesterday declared a regular dividend of 42 cents per share of common stock. The dividend will be payable on April 1, 2021, to stockholders of record on March 2, 2021. About McKesson Corporation McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmac
- 01/28/2021
|
McKesson (MCK) to Report Q3 Earnings: What's in the Offing?
- McKesson's (MCK) fiscal third-quarter results are likely to reflect solid show by U.S. Pharmaceutical and Specialty Solutions segment.
- 01/27/2021
|
McKesson: Capital Allocation Needs Urgent Attention
- McKesson's poor capital allocation policy results in an ineffective use of its generated free cash flow. Cash flow generated is being deployed on low return acquisitions or share buybacks in an inadequate attempt to buy growth.
- 01/19/2021
|
Here's Why You Should Invest in McKesson (MCK) Stock Now
- McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.
- 01/13/2021
|
4 Sector ETFs & Stocks to Bet on Q4 Earnings
- Sectors with positive earnings growth in Q4 include autos (86.3% earnings growth), construction (27.2%), basic materials (7.6%), medical (6.3%), and aerospace (4.4%).
- 01/12/2021
|
4 Dividend-Paying Undervalued MedTech Stocks for Gains in 2021
- Here we discuss four dividend-paying value stocks, MCK, CAH, BDX and HRC, which though trading cheap now, have solid chances of a rebound in the second half of 2021.
- 01/08/2021
|
Should Value Investors Buy McKesson (MCK) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 01/01/2021
|
MCK or CNMD: Which Is the Better Value Stock Right Now?
- MCK vs. CNMD: Which Stock Is the Better Value Option?
- 12/30/2020
|
5 Stocks That Could Hit Several New Highs in 2021
- Given the upbeat sentiments in the market, FedEx (FDX), Deere (DE), D.R. Horton (DHI), Fortescue (FSUGY) and Fiat Chrysler (FCAU) are expected to give good returns to investors in 2021.
- 12/29/2020
|
McKesson Corporation Announces Third Quarter Fiscal 2021 Earnings Release Date and Participation in January Conferences
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) will release its third quarter fiscal 2021 financial results before market open on Tuesday, February 2, 2021. The company will host a live webcast of the earnings conference call for investors at 8:00 AM Eastern Time to review its financial results. Additionally, McKesson management will be participating in the Goldman Sachs 13th Annual Healthcare CEOs Unscripted Conference on Tuesday, January 5, 2021 and the 39th Annual J.P. Morga
- 12/28/2020
|
5 Finest GARP Stocks Based on Discounted PEG
- Here we discuss five GARP stocks, TAP, OMI, TD, MCK and HMC, which while trading cheap at this moment, are generating robust growth rates on strong fundamentals.
- 12/24/2020
|
The InvestorPlace Q&A: Embrace the Food Revolution With the ANEW ETF
- The ANEW ETF is investing in companies pushing the boundaries of technology when it comes to feeding the planet. Here's what you need to know.
- 12/22/2020
|
Recession Proof McKesson Corporation Worth a Look on a Pullback
- As I stated last week, the healthcare sector is one of my favorite sectors to find recession proof companies. Consumers will, to the best of their abilities, seek out treatments for what ails them even in a difficult economic period.
- 12/21/2020
|
McKesson distribution centers ship first Moderna COVID-19 vaccines
- McKesson Corp., the giant health care distributor selected by the U.S. government to manage logistics for the COVID-19 vaccine immunization campaign, on Sunday began pushing out millions of doses of Moderna Inc.'s (NASDQ: MRNA) product in the back of FedEx and UPS trucks. On Monday, the express carriers will begin making deliveries to nearly 3,300 local dosing sites, and priority health care workers and residents of long-term care facilities will get vaccinated.
- 12/20/2020
|
ADDING MULTIMEDIA McKesson Fills Initial Government Orders for Moderna's COVID-19 Vaccine
- IRVING, Texas--(BUSINESS WIRE)--McKesson Fills Initial Government Orders for Moderna's COVID-19 Vaccine
- 12/20/2020
|
Top Stocks To Buy Today As Stimulus Hopes Send Markets To Mild Gains
- Optimism on the progress of stimulus talks sent markets to more mild gains. After markets closed at record highs on Thursday, stimulus hopes sent markets higher again.
- 12/18/2020
|
Goldman Sachs Adds Pharmaceutical Giant to Conviction List of Top Stocks to Buy
- With 2020 almost over and the new year just two short weeks away, many investors are resetting for what could be a volatile 2021.
- 12/16/2020
|
When a COVID-19 Vaccine Is Ready, This Company Is Prepared for Action
- One medical distribution company has been through this before.
- 12/08/2020
|
Ultra-Cold Freezer Makers To Profit From Covid-19 Vaccine Rush
- Excited about the Covid-19 vaccines from Pfizer and Moderna? You'll be waiting a long time unless the vaccines can be shipped at 94 degrees below zero.
- 11/21/2020
|
McKesson: A Buy The Dip Opportunity, With 26% Upside Potential
- McKesson's share price has reacted negatively on news of Amazon's entry into the pharmacy space. I see this reaction as being unwarranted. Meanwhile, McKesson continues to show operating strength, and the tentative opioid litigation settlement removes an overhang.
- 11/20/2020
|
Health Care Products Giant McKesson Earns Key Rating Upgrade
- McKesson shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. The post Health Care Products Giant McKesson Earns Key Rating Upgrade appeared first on Investor's Business Daily.
- 11/19/2020
|
Cramer delivers thoughts on vaccine distribution plays
- The "Mad Money" host explained why he's recommending the stocks of Carrier, McKesson and CVS Health to investors looking to get exposure to vaccine logistics.
- 11/16/2020
|
McKesson Corporation (MCK) CEO Brian Tyler on Q2 2021 Results - Earnings Call Transcript
- McKesson Corporation (MCK) CEO Brian Tyler on Q2 2021 Results - Earnings Call Transcript
- 11/03/2020
|
Covid Vaccine Distributor McKesson Hikes Guidance, Stock Jumps
- McKesson, which the U.S. government has tabbed to distribute the Covid-19 vaccines, posted quarterly earnings that easily topped views and hiked its earnings outlook, and MCK stock rose. The post Covid Vaccine Distributor McKesson Hikes Guidance, Stock Jumps appeared first on Investor's Business Daily.
- 11/03/2020
|
McKesson Corporation's (MCK) CEO Brian Tyler on Q2 2021 Results - Earnings Call Transcript
- McKesson Corporation's (MCK) CEO Brian Tyler on Q2 2021 Results - Earnings Call Transcript
- 11/03/2020
|
McKesson says potential opioid settlement proposal raised to up to $21 billion
- McKesson Corp said on Tuesday it and two other drug distributors could be expected pay up to $21 billion for the potential settlement of lawsuits alleging they fueled the U.S. opioid epidemic.
- 11/03/2020
|
McKesson's shares jump after beating earnings expectations
- Shares of McKesson Corp. gained 3.99% in premarket trading on Tuesday after it beat earnings expectations for the quarter. The drug distributor had earnings of $627 million, or $3.54 per share, in the second quarter of 2021, compared with a loss of $677 million, or a per-share loss of $3.99, in the same quarter a year ago.
- 11/03/2020
|
Walgreens Boots Alliance and McKesson Complete the Formation of German Wholesale Joint Venture
- DEERFIELD, Ill. & IRVING, Texas--(BUSINESS WIRE)--Walgreens Boots Alliance and McKesson announce the completion of their agreement to create a German wholesale joint venture.
- 11/02/2020
|
Global Operating Room Management Market (2020 to 2025) - Technological Advancements in Hospitals Presents Opportunities - ResearchAndMarkets.com
|
McKesson (NYSE:MCK) vs. (BTCA) (NYSE:BTCA) Head to Head Contrast
- McKesson (NYSE:MCK) and (BTCA) (OTCMKTS:BTCA) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership. Institutional and Insider Ownership 86.6% of McKesson shares are held by institutional investors. 0.3% of McKesson shares are […]
- 10/20/2020
|
Sanders Morris Harris LLC Invests $508,000 in McKesson Co. (NYSE:MCK)
- Sanders Morris Harris LLC acquired a new position in shares of McKesson Co. (NYSE:MCK) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,370 shares of the company’s stock, valued at approximately $508,000. Other hedge funds have also recently bought and sold shares […]
- 10/19/2020
|
McKesson’s Board of Directors Elects Linda Mantia as New Independent Director
- McKesson Corporation (NYSE: MCK) today announced that the McKesson board of directors has elected Linda Mantia as an independent director and member o
- 10/19/2020
|
Nachman Norwood & Parrott Inc Invests $51,000 in McKesson Co. (NYSE:MCK)
- Nachman Norwood & Parrott Inc bought a new position in shares of McKesson Co. (NYSE:MCK) in the third quarter, Holdings Channel.com reports. The fund bought 344 shares of the company’s stock, valued at approximately $51,000. Several other institutional investors have also added to or reduced their stakes in MCK. Westside Investment Management Inc. grew its […]
- 10/18/2020
|
Black Lives Matter's Alicia Garza: ‘Leadership today doesn't look like Martin Luther King’
- In seven years, BLM has gone from hashtag to global rallying cry. So why has the co-founder stepped away from the movement she helped create?
- 10/17/2020
|
Hexavest Inc. Sells 1,153 Shares of McKesson Co. (NYSE:MCK)
- Hexavest Inc. trimmed its position in shares of McKesson Co. (NYSE:MCK) by 5.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,269 shares of the company’s stock after selling 1,153 shares during the period. Hexavest Inc.’s holdings in McKesson were worth $2,721,000 […]
- 10/15/2020
|
CX Institutional Buys 17,235 Shares of McKesson Co. (NYSE:MCK)
- CX Institutional grew its stake in McKesson Co. (NYSE:MCK) by 15,252.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,348 shares of the company’s stock after acquiring an additional 17,235 shares during the period. CX Institutional’s holdings in McKesson were worth […]
- 10/14/2020
|
ASP Global, Leader in Direct Sourcing for Healthcare Systems, Names Industry Veteran Doug Shaver as CEO
- ASP Global has appointed Doug Shaver as Chief Executive Officer effective this week.
- 10/13/2020
|
Cypress Capital Group Boosts Stock Holdings in McKesson Co. (NYSE:MCK)
- Cypress Capital Group boosted its stake in shares of McKesson Co. (NYSE:MCK) by 1.0% during the third quarter, HoldingsChannel.com reports. The firm owned 7,998 shares of the company’s stock after acquiring an additional 83 shares during the period. Cypress Capital Group’s holdings in McKesson were worth $1,191,000 at the end of the most recent quarter. […]
- 10/09/2020
|
Old Port Advisors Sells 72 Shares of McKesson Co. (NYSE:MCK)
- Old Port Advisors trimmed its holdings in McKesson Co. (NYSE:MCK) by 4.3% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 1,589 shares of the company’s stock after selling 72 shares during the quarter. Old Port Advisors’ holdings in McKesson were worth $237,000 as of its most recent SEC filing. Other hedge funds have also […]
- 10/09/2020
|
McKesson Co. (NYSE:MCK) Stock Position Cut by Fulton Bank N. A.
- Fulton Bank N. A. lessened its stake in McKesson Co. (NYSE:MCK) by 7.3% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,489 shares of the company’s stock after selling 910 shares during the period. Fulton Bank N. A.’s holdings in McKesson were worth […]
- 10/07/2020
|
Connected Health And Wellness Devices Market Size Forecast 2020-2025 By Global Industry Trends, Development History, Business Opportunities, Share Estimation, Revenue, and Business Prospect, Says Industry Research Biz
- Oct 06, 2020 (The Expresswire) --
"Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Connected Health And Wellness...
- 10/06/2020
|
Digital Health Monitoring Market Research Report with Detailed Analysis 2020 & Forecast to 2026
- Oct 05, 2020 (Heraldkeepers) --
New York, October 5, 2020: The Global Digital Health Monitoring Market is expected to exceed more than US$ 254.5 Billion by...
- 10/05/2020
|
Two Sigma Advisers LP Has $1.38 Million Stock Holdings in McKesson Co. (NYSE:MCK)
- Two Sigma Advisers LP increased its holdings in shares of McKesson Co. (NYSE:MCK) by 350.0% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 9,000 shares of the company’s stock after purchasing an additional 7,000 shares during the period. Two Sigma Advisers LP’s holdings in McKesson were worth […]
- 10/04/2020
|
Clinical Decision Support System Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Forecasts, 2020-2024
- The Clinical Decision Support System market will register an incremental spend of about $1,274 million, growing at a CAGR of 17.91%
- 09/21/2020
|
$40+ Billion Electronic Medical Record Market - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016-2019 & 2020-2026 - ResearchAndMarkets.com
|
McKesson Ventures Grows Leadership Team with New Partner Promotions
- McKesson Ventures, the venture capital arm of McKesson Corporation, announces the expansion of its leadership team, promoting Jennifer Carter and Carr
- 09/16/2020
|
McKesson: On Solid Ground
- McKesson Corporation expects the goodwill of its Canada unit to be materially impaired in its Oct 1, 2020, review.
- 09/06/2020
|
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2020 Update
- Glenview Capital Management's 13F portfolio value decreased from $3.68B to $3.63B this quarter. The number of positions decreased from 44 to 43.
- 09/04/2020
|
McKesson: Still Cheap Despite Recent Gains
- The company posted a $2.77 earnings beat in Q1 on the back of a strong showing in June. Momentum expected to continue in Q2 and Q3.
- 08/31/2020
|
4 Dividend Increases For The Week Of August 30th With 1 Dividend King
- All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List.
- 08/27/2020
|
Synovus Financial Corp Has $318,000 Stake in McKesson Co. (NYSE:MCK)
- Synovus Financial Corp trimmed its holdings in McKesson Co. (NYSE:MCK) by 29.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,075 shares of the company’s stock after selling 857 shares during the period. Synovus Financial Corp’s holdings in McKesson […]
- 08/26/2020
|
Victory Capital Management Inc. Decreases Holdings in McKesson Co. (NYSE:MCK)
- Victory Capital Management Inc. trimmed its position in shares of McKesson Co. (NYSE:MCK) by 13.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 226,868 shares of the company’s stock after selling 34,658 shares during the period. Victory Capital Management Inc. […]
- 08/23/2020
|
Dividend Champion And Contender Highlights: Week Of August 23
- A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends.
- 08/22/2020
|
Broyhill Asset Management - H1 2020 Letter
- Broyhill Asset Management is a boutique investment firm, established as a family office and guided by a value orientation.
- 08/21/2020
|
Free pavement licenses for Crawley cafés, restaurants and bars - Crawley News 24
- Free pavement licenses for Crawley cafés, restaurants and bars
- 08/20/2020
|
PRESS DIGEST - Wall Street Journal - Aug. 19
|
McKesson Extends Partnership With CDC to Fight Coronavirus
- McKesson (MCK) extends partnership with the CDC to aid in the distribution of future COVID-19 vaccines.
- 08/18/2020
|
Drug-Distributor Stocks Rise as Opioid Settlement Looks Closer After Report on More Talks
- A group of state attorneys general are demanding more from Johnson & Johnson and the nation’s top drug distributors to settle the sprawling opioid litigation than the companies agreed to pay last year, according to a Tuesday report in The Wall Street Journal.
- 08/18/2020
|
U.S. states seek $26.4 bln from drug firms in opioid litigation - WSJ
|
WSJ News Exclusive | States Seek $26.4 Billion From Drug Companies in Opioid Litigation
- States are asking for around $26.4 billion from major pharmaceutical industry players to help pay for damage wrought by the opioid crisis, the latest demand in yearslong litigation seeking to hold companies accountable for widespread drug addiction.
- 08/18/2020
|
McKesson (MCK) Gains on Potential Vaccine Role
- Here's why McKesson (MCK) shares shot higher Friday. Trade the stock, along with two other drug distributors, with these tactical ideas.
- 08/17/2020
|
Tracking Seth Klarman's Baupost Group Holdings - Q2 2020 Update
- Seth Klarman’s 13F portfolio value increased from $6.77B to $8.01B this quarter. Baupost Group increased Atara Biotherapeutics while dropping Cheniere Energy.
- 08/15/2020
|
US Indexes Close Mostly Lower Friday
- Nasdaq up 23.07% for the year Continue reading...
- 08/14/2020
|
McKesson Tapped to Distribute Coronavirus Vaccines in U.S. | MarketScreener
|
USPS: Mail-in Ballots May Not Be Delivered in Time To Be Counted in 46 States
- • The U.S. Postal Service has warned 46 states and Washington, D.C. that mailed ballots may not be delivered in time to be counted, according to a Washington Post report. The global infection count has increased to nearly 21 million, with 760,761 deaths, according to data compiled by Johns Hopkins University. • President Donald Trump said Friday that (MCK)would partner with the U.S. government to distribute a coronavirus vaccine when one is approved.
- 08/14/2020
|
McKesson to Distribute Vaccine for Novel Coronavirus
- Aug.14 -- McKesson Corp. will help distribute a vaccine for the novel coronavirus in the U.S., President Donald Trump said on Friday, as part of the government’s efforts to speed an inoculation to the American public.
- 08/14/2020
|
McKesson and U.S. Join to Distribute Coronavirus Vaccine
- McKesson shares climbed after health-care supplier said it and the U.S. government would partner to distribute whichever coronavirus vaccine is approved.
- 08/14/2020
|
Illinois Cases Jump; N.J. Contact-Tracing Struggle: Virus Update
- (Bloomberg) -- California became the first U.S. state to top 600,000 confirmed infections. Illinois reported the most cases since May and Florida recorded more than 200 deaths for the third time in four days. New Jersey’s governor said the state is meeting public resistance to contact tracing.President Donald Trump said McKesson Corp will aid with vaccine distribution, even as more than a third of Americans in a survey said they wouldn’t get vaccinated. A rebound in U.S. retail sales slowed in July as Covid-19 infections surged.France said the situation is worsening, Spain closed nightclubs and Italy reported the most new infections since May. Greece ordered Athens-area bars and restaurants to close at midnight.Key Developments:Global Tracker: Global cases top 20.9 million; deaths pass 760,000Schumer backs $120 billion restaurant fund as aid talks sputterJamie Salter builds $15 billion empire from washed-up retailersCruise ship inquiry blasts Australian health officialsVirus vaccine rush leaves little recourse for anyone it harmsForced isolation may be the only way to stop resurgence of virusA fake shot may be your ticket to the front of the vaccine lineSubscribe to a daily update on the virus from Bloomberg’s Prognosis team here. Click CVID on the terminal for global data on coronavirus cases and deaths.California Tops 600,000 Cases (2:30 p.m. NY)California became the first U.S. state to top 600,000 confirmed infections, adding 7,934 cases Friday for a total of 601,075. The increase was above the 14-day average of 7,678, though data have been skewed by lab-reporting issues that caused a backlog of cases. The most-populous state reported 188 new deaths, bringing its total to 10,996.Hospitalizations from the virus fell 0.9% to 5,189 patients, the lowest since the end of June. They’ve declined 28% from a peak last month.Trump Unveils McKesson Distribution Deal (2:04 p.m. NY)President Donald Trump announced a collaboration with McKesson Corp to aid in vaccine distribution at a briefing on Friday.McKesson Corporation will be a central distributor of future Covid-19 vaccines and related supplies needed to administer the pandemic vaccinations, according to a press release from the U.S. Department of Health and Human Services.“Today’s announcement puts another building block in place as the Nation moves toward a safe and effective Covid-19 vaccine,” said Centers for Disease Control and Prevention Director Robert Redfield.New Jersey Struggles With Contact Tracing (1:35 p.m. NY)In New Jersey, 20% of people called by contact tracers in the past week didn’t answer, and 50% who did respond “refuse to provide information,” Governor Phil Murphy said at a Trenton news conference. He said the state wasn’t looking for evidence of illegal activity and urged residents to “work with and be honest” with the 1,529 tracers on the job.New Jersey reported 585 new cases in the past 24 hours, an increase of 0.3% compared with the prior seven-day average of 0.2%. To date, 15,903 deaths had a lab-confirmed or probable link to coronavirus, Murphy said.Illinois Cases Spike (12:25 p.m. NY)Illinois reported 2,264 new Covid-19 cases Friday, the largest daily total since May 24 as the state struggles to fend off a possible surge in virus infections. The number rose from 1,834 on Thursday.France Cases Rise (1:20 p.m. NY)France reported 2,846 new coronavirus cases on Friday up from 2,669 yesterday, health authorities said, the day after the U.K. declared that travelers from France would have to be quarantined.The virus is circulating more actively in Paris and Bouches-du-Rhone region where Marseilles is located. The authorities insisted on the importance of keep physical distancing. “We can all decide, collectively to massively slow down the epidemic.”Chile’s Cases Steady (12:30 p.m. NY)Chile reported 2,077 cases, a 0.6% rise compared with the 0.5% average daily increase in the previous seven days. Total cases are now 382,111. Another 41 deaths were reported, for a total of 10,340.Chile has reported more cases than Spain, a country with two-and-a-half times more inhabitants.Germany Says Spain a Risk (12:15 p.m. NY)Germany’s government on Friday declared mainland Spain and the Balearic islands as a virus risk area after infections continued to rise. Travelers returning from Spain -- a highly popular tourism destination for Germans -- will have to test for the virus and quarantine until they have obtained the result, a spokeswoman of the Health Ministry said. The Canary Islands are excluded from the measure.NYC Museums Can Reopen Aug. 24 (11:55 a.m. NY)New York City museums, aquariums and other low-risk indoor activities can reopen starting Aug. 24 with 25% occupancy, and timed, preset and staggered entry, Governor Andrew Cuomo said.Bowling alleys can reopen Monday with 50% occupancy and masks required, Cuomo said Friday on a call with reporters. The state will put out protocols on Monday for gyms, he said.The number of positive coronavirus cases in New York state has remained below 1% for seven straight days, Of the 85,455 tests reported on Thursday, 0.85% were positive. There were 554 people hospitalized, and four virus-related fatalities.The state is seeing several clusters of outbreaks among farm workers, and is dispatching mobile testing sites, Cuomo said.Italy Has Most New Cases Since May (11:45 a.m. NY)Italy registered 574 new coronavirus cases on Thursday, the highest since May 28.There were three additional deaths from the virus, according to data published by the Health Ministry. The increase was driven by 127 new cases in the Veneto region and 97 in Lombardy, the data showed.While the numbers remain much lower than the pandemic’s peak of 6,557 new infections in a day on March 21, they have been inching up this week. There were 523 new cases reported on Thursday. Total cases since late February rose to 252,809.Iceland Tightens Open Borders Policy (11:35 a.m. NY)Iceland’s government tightened rules for travelers to the island nation following criticism to its open borders policy amid a resurgence in Covid-19 cases.Prime Minister Katrin Jakobsdottir said the country will begin requiring double testing and a mandatory quarantine of four to five days for foreign tourists and Icelanders returning from holidays abroad between tests. The measures, among several steps proposed by the country’s chief epidemiologist, will take effect on Aug. 19.Florida Reports More Than 200 Deaths (10:55 a.m. NY)Florida reported 563,285 Covid-19 cases on Friday, up 1.1% from a day earlier, compared with an average increase of 1.3% in the previous seven days. Deaths among Florida residents reached 9,141, an increase of 228, or 2.6%, according to the health department report, which includes data through Thursday. It was the third daily tally above 200 in four days.Speaking Thursday in Tallahassee, Governor Ron DeSantis warned that more Covid-19 deaths may be coming at nursing homes and assisted-living facilities. He said protective measures have meant it takes longer for Covid-19 to breach the facilities, so they may see impacts after the peak in the general public.The new daily rate of people testing positive for the first time fell to 8.1% for Thursday, the lowest since June 21.Spain Closes Clubs, Limits Smoking (10:50 a.m. NY)Spain, the country with the most cases in Europe, is closing nightclubs and calling on local authorities to enforce a law that bans drinking in the streets under measures announced Friday. Smoking was prohibited if people can’t maintain a distance of at least two meters (6 1/2 feet) in a bid to prevent clusters of smokers outside nightspots and restaurants.Bars will close at 1 a.m. and table sizes will be restricted to no more than 10 people, Health Minister Salvador Illa told reporters. All of the measures are meant to stem the spread of the virus among younger people.N.J. to Use Mail-In Voting (10:15 a.m. NY)New Jersey Governor Phil Murphy said he will order the November general election to be conducted mostly through mail-in voting in a system he called “a little bit more cumbersome.”The general election format will be similar to that of the state’s July 7 primary. The state, in an unprecedented move, sent vote-by-mail applications to every registered voter -- 6.2 million people, according to state data -- and also opened some polling places.This time, the state will “have more presence of secure drop boxes,” he said in a CNN interview on Friday.Greece Limits Bars as Cities Fill Up Again (10 a.m. NY)Greece ordered Athens-area bars and restaurants to close at midnight to stem a virus surge as people return to the mainland from island vacations. Social events such as weddings will be limited to 50 people in worst-hit parts of the country under the measures, which apply until Aug. 24, Deputy Citizen Protection Minister Nikos Hardalias said Friday.Mask-wearing of masks is strongly recommended in all enclosed spaces and open areas where social distancing isn’t possible, Hardalias said. Greece recorded 263 new coronavirus cases on Wednesday, the biggest daily number yet.U.S. Retail Sales Rebound Slows (8:35 a.m. NY)A rebound in U.S. retail sales slowed sharply in July, indicating a surge in coronavirus cases and still-high unemployment cooled the economic recovery. The value of retail purchases increased 1.2% from the prior month after an upwardly revised 8.4% gain in June, according to Commerce Department data.Norway Recommends Wider Use of Masks (8 a.m. NY)Health officials in Norway recommended the use of face coverings in certain situations and parts of the country amid an increasing number of Covid-19 cases. It’s expected that the guidance will apply to public transport in the capital, Oslo.India’s Home Minister Tests Negative (7:45 a.m.
- 08/14/2020
|
McKesson Stock Jumps After Trump Says Company Would Distribute the Coronavirus Vaccine
- • President Donald Trump said Friday that (MCK)would partner with the U.S. government to distribute a coronavirus vaccine when one is approved. Speaking at a White House news conference, Trump said the joint effort was being taken under the federal government’s Operation Warp Speed, which aims to deliver Covid-19 vaccine doses to the American public. Shares of McKesson were up nearly 3% in recent trading action.
- 08/14/2020
|
Trump says McKesson Corp. to distribute coronavirus vaccine under Operation Warp Speed
- President Donald Trump said Friday that McKesson Corp. would partner with the U.S. government to distribute a coronavirus vaccine when one is approved. Speaking at a White House news conference, Trump said the joint effort was being taken under the federal government's Operation Warp Speed, which aims to deliver COVID-19 vaccine doses to the American public. Shares of McKesson were up nearly 3% in recent trading action.
- 08/14/2020
|
McKesson to Distribute Future COVID-19 Vaccines in Support of Operation Warp Speed
- A global leader in the healthcare industry, McKesson Corporation (NYSE: MCK) will expand its existing partnership with the Centers for Disease Control (CDC) to support the U.S. government’s Operation Warp Speed (OWS) team as a centralized distributor of future COVID-19 vaccines and ancillary supplies needed to administer vaccinations. Vaccines and related supplies will be delivered to point-of-care sites across the country at the U.S. government’s direction.
- 08/14/2020
|
Trump Administration picks McKesson for coronavirus vaccine distribution
|
Dow Ends Slightly Higher After Market Wavers on Uncertainty
|
Brandes Investment Seeing Profits on 2nd-Quarter Buys
- Additional holdings seeing positive gains Continue reading...
- 08/13/2020
|
'no longer commercially viable' - LloydsPharmacy to close in Tilgate, Crawley - Crawley News 24
- 'no longer commercially viable' - LloydsPharmacy to close in Tilgate, Crawley
- 08/11/2020
|
McKesson names Western University graduate to head its Canadian operations - BNN Bloomberg
- McKesson Corp. has appointed Rebecca McKillican as chief executive of its Canadian operations, effective immediately.
- 08/10/2020
|
McKesson Canada Names Rebecca McKillican Chief Executive Officer
- McKesson Corporation today announced the appointment of Rebecca McKillican as Chief Executive Officer (CEO), McKesson Canada effective immediately. Mc
- 08/10/2020
|
Nine Dividend Paying Companies Raising Dividends Last Week
- As part of my monitoring process, I review the list of dividend increases every week. This exercise helps me to monitor existing portfolio holdings, and to identify promising companies for further research. I tend to focus my attention on companies with at least ten years of annual dividend increases. This activity helps me to focus on companies with […]
- 08/09/2020
|
Insights on the Global Alcohol Prep Pads Market 2020-2024 | COVID-19 Analysis, Drivers, Restraints, Opportunities and Threats | Technavio
- The Global Alcohol Prep Pads Market will grow by USD 160.61 mn during 2020-2024
- 08/07/2020
|
Cross-Sector: Market Data Highlights
|
Cerner and Xealth Collaboration Helps Patients be More Active Participants in Health Care, Well-being
- Xealth and Cerner Corporation are working to bring digital health tools to clinicians and patients to improve the health care experience.
- 08/06/2020
|
Getting In Cheap On McKesson Corporation (NYSE:MCK) Might Be Difficult
- With a price-to-earnings (or "P/E") ratio of 29.7x McKesson Corporation (NYSE:MCK) may be sending very bearish signals...
- 08/05/2020
|
Three more major Crawley stores with potential job losses due to COVID-19 - Crawley News 24
- Three more major Crawley stores with potential job losses due to COVID-19
- 08/05/2020
|
Healthcare IT Market Analysis Highlights the Impact of COVID-19 (2020-2024) | Need for Automation Across Departments to Boost Market Growth | Technavio
- The Global Healthcare IT Market will grow by USD 95.98 bn during 2020-2024
- 08/05/2020
|
Pzena Investment Cuts Amgen, Halliburton
- Firm's largest sales of the 2nd quarter Continue reading...
- 08/04/2020
|
McKesson Beats 2Q Estimates, UBS Lifts PT
- Shares of McKesson are rising in pre-market trading after the healthcare services provider posted better-than-expected 2Q earnings and raised its fiscal
- 08/04/2020
|
Company News for Aug 4, 2020
- Companies In The News Are: TSN, MCK, MCY, TKR.
- 08/04/2020
|
Here are Tuesday's biggest analyst calls of the day: Disney, Roku, Zillow & more
- Here are the biggest calls on Wall Street on Tuesday
- 08/04/2020
|
McKesson Beats 2Q Estimates, UBS Lifts PT
- Shares of McKesson are rising in pre-market trading after the healthcare services provider posted better-than-expected 2Q earnings and raised its fiscal 2021 guidance. The stock is up about 1% in the pre-market session after surging over 6.5% yesterday.McKesson’s (MCK) adjusted earnings of $2.77 per share beat analysts’ expectations of $2.32. Its revenues of $55.7 billion also surpassed Street estimates of $54 billion. The company’s CEO, Brian Tyler said, "Thanks to the strong execution of our employees around the world, McKesson delivered first-quarter results ahead of our original expectations, as volumes across the business improved earlier than anticipated.”Buoyed by better-than-expected quarterly results, McKesson raised its adjusted EPS guidance range for fiscal 2021 to $14.70-$15.50 from $13.95-$14.75.UBS analyst Kevin Caliendo raised the stock's price target to $170 (6.3% upside potential) from $165 and maintained a Buy rating. On July 8, Guggenheim analyst Glen Santangelo raised the price target to $175 from $168 and reiterated a Buy, saying “the risk/reward is attractive heading into the Q1 earnings report." He further stated that “healthcare facilities and provider offices have reopened at a healthy pace, and key customers have offered encouraging commentary.”Overall, MCK analysts have a cautiously optimistic Moderate Buy consensus on the stock. The average price target of $171.83 implies upside potential of 7.5%. (See MCK stock analysis on TipRanks).Related News: Chegg’s 2Q Profit Soars 61% On Strong Demand After Amazon Trounces 2Q Estimates, 5-Star Analyst Says There’s More to Come Goldman Upgrades Merck To Buy, Lifts PT More recent articles from Smarter Analyst: * Abiomed’s Impella Scores Emergency FDA Nod For Covid-19 Patients * Merck, Hanmi Seal Licence Deal For Fatty Liver Disease Therapy * TikTok Parent ByteDance Accuses Facebook Of ‘Plagiarism And Smear’ * Chegg’s 2Q Profit Soars 61% On Strong Demand
- 08/04/2020
|
A Peek Into The Markets: US Stock Futures Edge Lower Following Monday's Rally
- Pre-open movers
U.S. stock futures traded slightly lower in early pre-market trade, after posting gains in the previous session. Investors are awaiting earnings results from...
- 08/04/2020
|
S&P 500 Up 24 Points: Microsoft Moving on TikTok, Apple Going After Payments? | The Motley Fool
- One small acquisition and ongoing negotiations on a much bigger one had two megacaps lifting the index higher today.
- 08/03/2020
|
McKesson Corp. (NYSE: MCK) Q1 2021 Earnings Call Transcript | AlphaStreet
- Final earnings conference call transcript of McKesson Corp. - MCK stock
- 08/03/2020
|
US STOCKS-Nasdaq hits record high close as traders eye M&A and stimulus
- The Nasdaq surged to a record high close on Monday as a rebound in multibillion-dollar deals, including Microsoft's pursuit of TikTok's U.S. operations, lifted sentiment, and efforts to hammer out a coronavirus relief bill resumed. Microsoft jumped 5.6% after it said it would push ahead with talks to buy the U.S. operations of Chinese-owned TikTok. President Donald Trump reversed course earlier on a planned ban of the short-video app.
- 08/03/2020
|
McKesson Corp (MCK) Q1 2021 Earnings Call Transcript | The Motley Fool
- MCK earnings call for the period ending June 30, 2020.
- 08/03/2020
|
US STOCKS-Wall St jumps as traders eye M&A and stimulus
- Wall Street rallied on Monday as a rebound in multibillion-dollar deals, including Microsoft's pursuit of TikTok's U.S. operations, lifted sentiment, and efforts to hammer out a coronavirus relief bill resumed. Microsoft jumped 4.8% after it said it would push ahead with talks to buy the U.S. operations of Chinese-owned TikTok. President Donald Trump reversed course earlier on a planned ban of the short-video app.
- 08/03/2020
|
How McKesson's Mixed Q1 Results Still Beat Wall Street Estimates | The Motley Fool
- The big healthcare company faced COVID-19 headwinds. But its business improved more strongly than expected.
- 08/03/2020
|
US STOCKS-Microsoft, Apple lift Wall St as investors await stimulus
- Wall Street's main indexes rose on Monday as a rebound in multi-billion dollar deals, including Microsoft's pursuit of TikTok's U.S. operations, lifted sentiment as efforts to hammer out a coronavirus relief bill resumed. Microsoft jumped 4% on saying it would push ahead with talks to buy the U.S. operations of Chinese-owned TikTok after President Donald Trump reversed course on a planned ban of the short-video app.
- 08/03/2020
|
CORRECTED-US STOCKS-Earnings, Microsoft boost Wall St as investors await stimulus
- Wall Street's main indexes rose on Monday as Microsoft's pursuit of TikTok's U.S. operations and a clutch of upbeat quarterly earnings reports lifted sentiment in the absence of a fiscal coronavirus relief deal. Microsoft jumped 3.7% as it said it would push ahead with talks to acquire the U.S. operations of Chinese-owned TikTok after President Donald Trump reversed course on a planned ban of the short-video app.
- 08/03/2020
|
McKesson (MCK) Q1 Earnings and Revenues Surpass Estimates
- McKesson's (MCK) fiscal first-quarter 2021 results benefit from strong U.S. Pharmaceutical and Specialty Solutions segment.
- 08/03/2020
|
McKesson (MCK) Beats Q1 Earnings and Revenue Estimates
- McKesson (MCK) delivered earnings and revenue surprises of 17.87% and 3.02%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 08/03/2020
|
CORRECTED-US STOCKS-Earnings, Microsoft set to boost Wall St as investors await stimulus
- Wall Street's main indexes were set to open higher on Monday as Microsoft's pursuit of TikTok's U.S. operations and a clutch of upbeat quarterly earnings reports lifted sentiment in the absence of a fiscal coronavirus relief deal. Microsoft rose 2.7% before the bell as it said it would push ahead with talks to acquire the U.S. operations of Chinese-owned TikTok after President Donald Trump reversed course on a planned ban of the short-video app.
- 08/03/2020
|
Stocks making the biggest moves in the premarket: ADT, Google, Clorox, Eli Lilly, Marathon Petroleum & more
- The stocks making the biggest moves in premarket trading include ADT, Google, Clorox, Eli Lilly, Marathon Petroleum, and more.
- 08/03/2020
|
McKesson's stock jumps after profit and revenue beats, raised outlook
- Shares of McKesson Corp. undefined climbed 1.9% in premarket trading Monday, after the drug distributor and health care services company reported fiscal...
- 08/03/2020
|
McKesson's stock jumps after profit and revenue beats, raised outlook
- Shares of McKesson Corp. climbed 1.9% in premarket trading Monday, after the drug distributor and health care services company reported fiscal first-quarter profit and revenue that beat expectations, and raised its full-year outlook. Net income for the quarter to June 30 grew to $444 million, or $2.72 a share, from $423 million, or $2.24 a share, in the year-ago period. Excluding non-recurring items, adjusted earnings per share fell to $2.77 from $3.31 but was above the FactSet consensus of $2.35. Revenue slipped to $55.68 billion from $55.73 billion but topped the FactSet consensus of $53.85 billion, as a 2% increase in U.S. pharmaceutical sales to $45.06 billion beat expectations of $44.14 billion. For fiscal 2021, the company raised its adjusted EPS guidance range to $14.70 to $15.50 from $13.95 to $14.75, to reflect an improvement in volumes that came earlier than originally expected. The stock has gained 8.6% year to date through Friday, while the SPDR Health Care Select Services ETF has tacked on 3.6% and the S&P 500 has edged up 1.3%.
- 08/03/2020
|
McKesson : Reports Fiscal 2021 First-Quarter Results | MarketScreener
|
McKesson Reports Fiscal 2021 First-Quarter Results
- McKesson Corporation (NYSE:MCK) today reported results for the first quarter ended June 30, 2020.
- 08/03/2020
|
US STOCKS-Stimulus gridlock strains S&P 500, Dow futures
- Futures linked to the S&P 500 and the Dow indexes were muted on Monday with lawmakers at an impasse about a coronavirus relief deal, while investors remained cautious after Fitch revised its U.S. outlook to negative, citing eroding credit strength. After an extra $600-per-week in jobless benefits expired last week, White House Chief of Staff Mark Meadows said on Sunday he was not optimistic about reaching an agreement soon for the next relief bill. With jobless claims rising again, all eyes this week will be on the Labor Department's employment report this Friday, which is expected to show far fewer jobs being created in July after a record surge in the previous month.
- 08/03/2020
|
McKesson Reports Fiscal 2021 First-Quarter Results
- McKesson Corporation (NYSE:MCK) today reported results for the first quarter ended June 30, 2020. Fiscal 2021 First-Quarter Result Summary First-Q
- 08/03/2020
|
Disney, T-Mobile, CVS, Activision Blizzard, and Other Stocks for Investors to Watch This Week
- Second-quarter earnings season continues with results from Disney, T-Mobile, Fox, ViacomCBS, and Clorox. Video-game makers Take-Two and Activision Blizzard also report. Plus, July jobs data.
- 08/02/2020
|
Dividend Champion And Contender Highlights: Week Of August 2
- A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends.
- 08/01/2020
|
Zurcher Kantonalbank Zurich Cantonalbank Reduces Stock Holdings in McKesson Co. (NYSE:MCK)
- Zurcher Kantonalbank Zurich Cantonalbank decreased its holdings in McKesson Co. (NYSE:MCK) by 31.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 36,059 shares of the company’s stock after selling 16,234 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in McKesson were […]
- 08/01/2020
|
Allegiant Flies Above the Pack With Its Budget-Meets-Leisure Formula
- In a year in which airlines have gotten hammered by the pandemic, a carrier with ultralow costs and flexible scheduling takes the lead. Not that the flight may not get a little rough.
- 08/01/2020
|
The jobs report and congressional politics may matter more for markets than earnings in the week ahead
- The market could lose some exuberance as the calendar turns to August, and investors await Friday's July employment report.
- 07/31/2020
|
'Devastating' Crawley's Hollywood Bowl reaction to Government U-turn on reopening - Crawley News 24
- 'Devastating' Crawley's Hollywood Bowl reaction to Government U-turn on reopening
- 07/31/2020
|
10 Biggest Health Care Companies
- With CVS Health in the 1 spot, these are the 10 biggest health care companies by trailing 12-month revenue.
- 07/30/2020
|
McKesson (MCK) to Post Q1 Earnings: What's in the Offing?
- McKesson's (MCK) fiscal first-quarter results are likely to reflect solid show by U.S. Pharmaceutical and Specialty Solutions segment.
- 07/30/2020
|
McKesson Corporation : quaterly earnings release | MarketScreener
|
Over 30 Crawley businesses sign up to half-price dining as Council encourages more to join - Crawley News 24
- Over 30 Crawley businesses sign up to half-price dining as Council encourages more to join
- 07/29/2020
|
COVID-19 Impacts: Digital Health Market will Accelerate at a CAGR of over 20% through 2020-2024 | Increase in the Number of M&A Activities to Boost Growth | Technavio
- The Global Digital Health Market will grow by $ 207.34 bn during 2020-2024
- 07/27/2020
|
Stocks To Watch: Big Focus On Big Tech
- Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
- 07/25/2020
|
Belpointe Asset Management LLC Increases Stock Position in McKesson Co. (NYSE:MCK)
- Belpointe Asset Management LLC raised its holdings in McKesson Co. (NYSE:MCK) by 44.7% during the second quarter, Holdings Channel.com reports. The firm owned 5,914 shares of the company’s stock after purchasing an additional 1,826 shares during the quarter. Belpointe Asset Management LLC’s holdings in McKesson were worth $907,000 as of its most recent filing with […]
- 07/22/2020
|
Heritage Wealth Advisors Acquires 8,488 Shares of McKesson Co. (NYSE:MCK)
- Heritage Wealth Advisors grew its holdings in McKesson Co. (NYSE:MCK) by 1,670.9% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,996 shares of the company’s stock after acquiring an additional 8,488 shares during the period. Heritage Wealth Advisors’ holdings in McKesson were worth […]
- 07/19/2020
|
Quidel’s Sofia® SARS Antigen FIA Updates EUA Performance Data to 96.7% PPA Versus PCR; Product Supports U.S. Initiatives to Expand Access to COVID-19 Testing in Nursing Homes; Receives CE Mark for Use With Sofia® and Sofia® 2 Instruments
- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnosti
- 07/18/2020
|
CENTRAL TRUST Co Raises Stock Position in McKesson Co. (NYSE:MCK)
- CENTRAL TRUST Co lifted its holdings in shares of McKesson Co. (NYSE:MCK) by 14.1% during the 2nd quarter, Holdings Channel reports. The firm owned 3,496 shares of the company’s stock after buying an additional 431 shares during the period. CENTRAL TRUST Co’s holdings in McKesson were worth $536,000 as of its most recent SEC filing. […]
- 07/17/2020
|
Louisiana State Employees Retirement System Grows Stock Holdings in McKesson Co. (NYSE:MCK)
- Louisiana State Employees Retirement System raised its stake in shares of McKesson Co. (NYSE:MCK) by 1.4% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 7,000 shares of the company’s stock after acquiring an additional 100 shares during the period. Louisiana State […]
- 07/16/2020
|
McKesson Named One of the Best Places to Work for Disability Inclusion
- McKesson today announced that The Disability Equality Index (DEI) has named the company as one of its 2020 Best Places to Work for Disability Inclusio
- 07/16/2020
|
Here's Why You Should Retain McKesson (MCK) Stock for Now
- McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.
- 07/15/2020
|
Kit Check Adds General Counsel to Support Continuous Strategic Growth
- Attorney Mialeeka Williams-Bibbs has joined the Kit Check team amid company’s push to continue to revolutionize the medication supply chain
- 07/15/2020
|
Health Fidelity Expands Commercial Team to Support Accelerated Growth
- Health Fidelity has added a new SVP of client development to oversee solution architecture, sales, and account management efforts.
- 07/14/2020
|
Here Are a Few Sectors and Three Dozen Stocks That Strategists Think Will Rise on a Blue Wave
- Strategists in recent days have been gaming out market implications of a Democratic sweep in November’s elections, with sectors that stand to benefit including infrastructure and green technology.
- 07/07/2020
|
What to watch today: Dow to drop as tech pauses, reopen stocks stumble
- Dow futures fell Tuesday, with high-flying tech stocks pausing and so-called reopening stocks declining.
- 07/07/2020
|
Stocks making the biggest moves in the premarket: Novavax, Regeneron, Square, Nvidia & more
- The stocks making the biggest moves in premarket trading include Novavax, Regeneron, Square, Nvidia, and more.
- 07/07/2020
|
McKesson Corporation to Announce First Quarter Fiscal 2021 Results on August 3, 2020 | | IT Business Net
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) will release its first quarter fiscal 2021 financial results before market open on Monday, August 3, 2020. The company will host a live
- 07/06/2020
|
McKesson Corporation : to Announce First Quarter Fiscal 2021 Results on August 3, 2020 | MarketScreener
|
McKesson Corporation to Announce First Quarter Fiscal 2021 Results on August 3, 2020
- McKesson Corporation (NYSE:MCK) will release its first quarter fiscal 2021 financial results before market open on Monday, August 3, 2020. The company will host a live webcast of the earnings conference call for investors at 8:00 AM Eastern Time to review its financial results.
- 07/06/2020
|
Nervous time for Crawley & Gatwick Pret A Manger shops as chain announces closure of 30 shops and at least 1,000 job losses - Crawley News 24
- Nervous time for Crawley & Gatwick Pret A Manger shops as chain announces closure of 30 shops and at least 1,000 job losses
- 07/06/2020
|
Fulton Bank N. A. Cuts Holdings in McKesson Co. (NYSE:MCK)
- Fulton Bank N. A. reduced its position in McKesson Co. (NYSE:MCK) by 5.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,399 shares of the company’s stock after selling 768 shares during the quarter. Fulton Bank N. A.’s holdings in McKesson were worth $1,903,000 […]
- 07/06/2020
|
Global Colposcopes Market 2020-2026 Featuring Profiles of Leading Players Danaher, McKesson, Olympus, Carl Zeiss, The Cooper Companies, DYSIS Medical, and More - ResearchAndMarkets.com
|
McKesson Realigns Organizational Structure to Better Serve Customers and Patients While Optimizing Growth | | IT Business Net
- IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) today announces changes to its reportable business structure. The Company has revised its reportable segments commencing in the second q
- 07/01/2020
|
McKesson : Changes Business-Unit Structure | MarketScreener
|
McKesson : Realigns Organizational Structure to Better Serve Customers and Patients While Optimizing Growth | MarketScreener
|
McKesson Realigns Organizational Structure to Better Serve Customers and Patients While Optimizing Growth
- McKesson Corporation (NYSE:MCK) today announces changes to its reportable business structure. The Company has revised its reportable segments commencing in the second quarter of fiscal 2021.
- 07/01/2020
|
Pollster With Fake Staff Gave Top Grades to Firms Landing Deals - BNN Bloomberg
- Everyone knows Yelp reviews are unscientific.
- 07/01/2020
|
Change Healthcare (NASDAQ:CHNG) Downgraded by Zacks Investment Research to Sell
- Change Healthcare (NASDAQ:CHNG) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Monday, Zacks.com reports. They presently have a $9.00 price target on the stock. Zacks Investment Research‘s price objective points to a potential downside of 18.70% from the stock’s current price. According […]
- 07/01/2020
|
McKesson Realigns Organizational Structure to Better Serve Customers and Patients While Optimizing Growth
- McKesson Corporation (NYSE:MCK) today announces changes to its reportable business structure. The Company has revised its reportable segments commenci
- 07/01/2020
|
Karyopharm Therapeutics : XPOVIO, FDA Approved for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma, Available at Biologics by McKesson | MarketScreener
|
CARDINAL HEALTH, INC. : Ex-dividend day for | MarketScreener
|
The Global Cancer Registry Software Market is expected to grow from USD 56.77 Million in 2019 to USD 105.82 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 10.93%
- Market Segmentation & Coverage: This research report categorizes the Cancer Registry Software to forecast the revenues and analyze the trends in each of the following sub-markets:
- 06/30/2020
|
CARDINAL HEALTH, INC. : Détachement de dividende | Zone bourse
|
Were Hedge Funds Right About Betting On McKesson Corporation (MCK)?
- We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st, near the height of the coronavirus market crash. We are almost done with the second quarter. Investors decided […]
- 06/29/2020
|
McKesson : XPOVIO (selinexor), FDA Approved for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL), Available at Biologics by McKesson | MarketScreener
|
ZUR ROSE GROUP : Warburg Research reste à l'achat | Zone bourse
|
COVID-19 Impact and Recovery Analysis | Clinical Decision Support System Procurement Intelligence Report Forecasts Spend Growth of Over USD 1,274 Billion
- The global Clinical Decision Support System Procurement Intelligence Report Forecasts Spend Growth of over USD 1,274 billion between 2020-2024
- 06/29/2020
|
McKesson Co. (NYSE:MCK) Shares Bought by Clearbridge Investments LLC
- Clearbridge Investments LLC raised its stake in McKesson Co. (NYSE:MCK) by 41,302.7% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 93,156 shares of the company’s stock after acquiring an additional 92,931 shares during the quarter. Clearbridge Investments LLC owned approximately 0.05% […]
- 06/28/2020
|
McKesson Co. (NYSE:MCK) Shares Bought by Optimal Asset Management Inc.
- Optimal Asset Management Inc. grew its holdings in shares of McKesson Co. (NYSE:MCK) by 109.1% in the first quarter, according to its most recent filing with the SEC. The firm owned 4,205 shares of the company’s stock after acquiring an additional 2,194 shares during the quarter. Optimal Asset Management Inc.’s holdings in McKesson were worth […]
- 06/28/2020
|
Shaun King calls for white Jesus statues to be torn down
- Shaun King waded into the debate over statues when he tweeted that figures of Jesus as a white man are 'a form of white supremacy' and should be toppled.
- 06/27/2020
|
Dividend Champion And Contender Highlights: Week Of June 28
- A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
- 06/27/2020
|
Everything You Need to Know About GoodRx | The Motley Fool
- Could this drug couponing start-up be headed for IPO or is it a takeover target? Either way, it's helping consumers save billions at the pharmacy.
- 06/27/2020
|
Don't Buy Falling Financials, Buy These Stocks Instead
- Stress test results put the brakes on banking stocks. Healthcare and technology are better sectors for alpha-generating ideas. Top stocks to add to watch lists
- 06/27/2020
|
Don't Buy Falling Financials, Buy These Stocks Instead
- Stress test results put the brakes on banking stocks. Healthcare and technology are better sectors for alpha-generating ideas. Top stocks to add to watch lists
- 06/26/2020
|
Telehealth start-up Ro has hit record sales every month since expanding pharmacy business pre-pandemic
- Ro, which previously specialized in men's health, is now generating $250 million in annual revenue after expanding its product line.
- 06/26/2020
|
ZUR ROSE GROUP : Warburg Research optimiste sur le dossier | Zone bourse
|
Thrivent Financial for Lutherans Lowers Holdings in McKesson Co. (NYSE:MCK)
- Thrivent Financial for Lutherans lowered its holdings in shares of McKesson Co. (NYSE:MCK) by 70.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,361 shares of the company’s stock after selling 17,638 shares during the quarter. Thrivent Financial for Lutherans’ holdings […]
- 06/26/2020
|
COVID-19 Impact and Recovery Analysis - Digital Health Market 2020-2024 | Increase in the Number of M&A Activities in the Market to Boost Growth | Technavio
- The Global Digital Health Market will grow by $ 207.34 bn during 2020-2024
- 06/26/2020
|
Cresco Labs Announces Retirement of Ken Amann and Appointment of Dennis Olis as Chief Financial Officer
- Mr. Amann to remain in an advisory role as part of the planned transitionCHICAGO — Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest v…
- 06/25/2020
|
Australian device maker strikes partnership with the U.S. Oncology Network
- Impedimed, which is headquartered in Australia, makes a tool for early detection of lymphedema in cancer patients.
- 06/25/2020
|
7 Picks For June 2020: 3 Of Them Are Severely Undervalued
- After euphoria kicking in and retail investors entering the market, the US stock market is once again extremely overvalued making it hard to find great investme
- 06/25/2020
|
Cresco Labs Announces Retirement of Ken Amann and Appointment of Dennis Olis as Chief Financial Officer
- Cresco Labs Announces Retirement of Ken Amann and Appointment of Dennis Olis as Chief Financial Officer
- 06/25/2020
|
Hospital Consumables Market 2020 Covid-19 Impact on Global Demand, Sales, Consumption and Forecasts to 2026
- Wiseguyreports.Com Publish Market Report On-“Hospital Consumables Market 2020 Global Analysis by Sales, Demand, Trends, Consumption and Growth, Forecast 2026”
- 06/24/2020
|
The Global Cardiology Information System Market is expected to grow from USD 240.72 Million in 2019 to USD 410.47 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.30%
- Market Segmentation & Coverage: This research report categorizes the Cardiology Information System to forecast the revenues and analyze the trends in each of the following sub-markets:
- 06/24/2020
|
Sponaugle concedes in W.Va. Democratic attorney general race
- CHARLESTON, W.Va. (AP) — Isaac Sponaugle conceded the Democratic primary for West Virginia attorney general to labor lawyer Sam Petsonk on Tuesday, capping a close race decided by fewer than 200...
- 06/23/2020
|
Washington Files Suit Against 3 Opioid Distributors
- The lawsuit claims the distributors illegally shipped drugs into Washington for years, fueling the opioid epidemic.
- 06/23/2020
|
Wound Closure Strips - Global Industry Overview and Outlook to 2027 - ResearchAndMarkets.com
|
Assessing the Coronavirus Impact: Swab and Viral Transport Medium Market to Witness High Demand Growth with Rising Patient Numbers and Faster Product Approval Processes | | IT Business Net
- The COVID-19 pandemic is expected to see an increase in swab and viral transport product manufacturing capabilities to meet the unprecedented requirements of healthcare organizations, on a global scal
- 06/22/2020
|
Inspira Health’s Tom Baldosaro Honored as a “CFO of the Year” by the Philadelphia Business Journal
- Inspira Health announced that Chief Financial Officer Tom Baldosaro was selected by the Philadelphia Business Journal as a 2020 “CFO of the Year.” Bal
- 06/22/2020
|
McKesson Co. (NYSE:MCK) Stock Position Trimmed by Janus Henderson Group PLC
- Janus Henderson Group PLC cut its position in McKesson Co. (NYSE:MCK) by 5.2% during the 1st quarter, HoldingsChannel reports. The firm owned 38,979 shares of the company’s stock after selling 2,123 shares during the quarter. Janus Henderson Group PLC’s holdings in McKesson were worth $5,274,000 as of its most recent filing with the Securities & […]
- 06/21/2020
|
Activist DeRay Mckesson: Data from the FBI doesn't support current police funding
- He argues violent crime is 5% of all crime; the other 95% of police budgets could go elsewhere.
- 06/19/2020
|
McKesson (MCK) Up 5.2% Since Last Earnings Report: Can It Continue?
- McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 06/19/2020
|
McKesson : Partners with Walmart to Deliver nearly 10 million Critical Medical Gowns | MarketScreener
|
Assessment of COVID-19's Effect on Cancer Registry Software Market 2020-2024 | Growing Prevalence of Cancer Cases to Augment Growth | Technavio
- The Global Cancer Registry Software Market will grow by $ 34.81 mn during 2020-2024
- 06/19/2020
|
2020 Large Cap Stocks List - Sure Dividend
- Large cap stocks have market capitalizations above $10 billion. See our top 10 large cap stocks today plus a downloadable list of over 400 large cap stocks.
- 06/18/2020
|
How GoodRx built a $2.8 billion business by helping consumers find drug discounts
- GoodRx helps millions of consumers find the best prices at more than 70,000 pharmacies nationwide via its website and mobile app. It made the No. 20 spot on CNBC's 2020 Disruptor 50 list, released Tuesday.
- 06/17/2020
|
Global Digital Medicine Market is estimated to be US$ 18.6 Billion by 2029 with a CAGR of 23.5% during the Forecast Period - PMI
- The global digital medicine market accounted for US$ 2.3 billion in 2019 and is estimated to be US$ 18.6 billion by 2029 and is anticipated to register a CAGR
- 06/17/2020
|
Xilio Therapeutics Appoints Daniel S. Lynch as Chair of Board of Directors
- Xilio Therapeutics, a company developing potent, tumor-selective immunotherapies for patients with cancer, today announced that Daniel S. Lynch has be
- 06/17/2020
|
Insights on the Blockchain Global Market to 2025 - Key Drivers, Constraints & Challenges - ResearchAndMarkets.com
|
News Highlights : Top Company News of the Day
|
Opioid Deal May Be Sped Up Amid State Shortfalls, Analyst Says - BNN Bloomberg
- Companies tied to the opioid epidemic could see a smaller settlement with U.S. states in return for faster payments as local governments hit by the coronavirus face a fiscal crisis and dwindling tax base, according to Morgan Stanley analysts.
- 06/15/2020
|
Why We Like McKesson Corporation’s (NYSE:MCK) 15% Return On Capital Employed
- Today we are going to look at McKesson Corporation (NYSE:MCK) to see whether it might be an attractive investment...
- 06/15/2020
|
News Highlights: Top Company News of the Day
|
Can These Drug Stocks Fly? It Depends on the Lawyers
- Opioid and price-fixing legal woes should lead to volatile stock moves for generic-drug makers and distributors such as Teva and McKesson.
- 06/15/2020
|
Nissan Motor : Mark Sutcliffe is appointed Alliance Senior Vice President, Alliance LCV Business Unit | MarketScreener
|
